21/7'CL, AU-TO ID-IO-TYP-IC DE-TER-MI-NANT  ID R  ON MAB 28 12
L77'CL, HU-MAN CD4
A17'CL, IG-G1 MON-O-CLON-AL AU-TOAN-TI-BODY  RHEUMA-TOID FAC-TOR
RF-ET11'CL, RHEUMA-TOID FAC-TOR
1B5'CL, FE-CAL BAC-TE-RIA
Clone F'CL, RHEUMA-TOID FAC-TOR WHICH BOUND SPECIF-I-CAL-LY TO MRL IG-G2A AL-LO-TYPE  IGH 1J  BUT NOT B6 IG-G2A AL-LO-TYPE  IGH 1B
6-4'CL, IG-G2A
1-5F6'CL, SM HY-BRIDO-MA
25G07, LYSOZYME HY-BRIDO-MA
GER, MON-O-CLON-AL CRY-OIM-MUNOGLOB-U-LIN
bkv7'CL, IGG POLY-CLON-AL RHEUMA-TOID FAC-TOR
SA-4A'CL, TITIN AU-TOAN-TI-BODY
126TP6H'CL, THY-ROID PER-OX-I-DASE  TPO
1E8'CL, BO-TULINUM NEU-RO-TOX-IN TYPE A BIND-ING DO-MAIN  BONT A HC
Ab1 GA733'CL, HU-MAN TU-MOR AS-SO-CI-AT-ED ANTI-GEN GA733
B/SB5-72'CL, H4
305'CL, IN-SULIN
34-3C'CL, MOUSE RED BLOOD CELL AU-TOAN-TI-BOD-IES
Vl FUR2'CL, LAMIN B AU-TOAN-TI-BODY
Hb-3, FOETAL HAEMOGLOBIN  HBF
2F6F2'CL, TG
VH FUR2'CL, LAMIN B AU-TOAN-TI-BODY
RF-ET9'CL, RHEUMA-TOID FAC-TOR
D15'CL, RH D
TB-1-P7'CL, RHEUMA-TOID FAC-TOR
1-18'CL, SM HY-BRIDO-MA
RF4-3FK'CL, IG-G1
3B12-3'CL, 88 KDA SPLIC-ING FAC-TOR 53 4
BrM4'CL, E. COLI  BROME-LAIN TREAT-ED MOUSE RBC  TRIMETHY-LAM-MO-NI-UM HY-BRIDO-MA
G10-1'CL, HU-MAN CD8
3G2'CL, SM HY-BRIDO-MA
A12'CL, IG-G1 MON-O-CLON-AL AU-TOAN-TI-BODY  RHEUMA-TOID FAC-TOR
2INL2'CL, HU-MAN IN-SULIN
7F'CL, THY-ROID PER-OX-I-DASE AU-TOAN-TI-BODY
RF-TMC'CL, MONORE-AC-TIVE RHEUMA-TOID FAC-TOR
D83, MOUSE KAP-PA LIGHT CHAIN  P AZOPHENY-LAR-SON-ATE BSA  ARS BSA   ID-IO-TYPE
43F10'CL, RH D
4D11F4'CL, TG
AHT107'CL, HU-MAN P55 IL 2 RE-CEP-TOR
bkv33'CL, IGG POLY-CLON-AL RHEUMA-TOID FAC-TOR
CEA4-8A'CL, HU-MAN CAR-CI-NOEM-BRY-ON-IC ANTI-GEN
2INL7'CL, HU-MAN IN-SULIN
72-2'CL, PE-RIPH-ERIN AU-TOAN-TI-BODY
RF-4 PAN'CL, IGG PAN RHEUMA-TOID FAC-TOR
3-7'CL, SM  SS-D-NA
TEL13'CL, TURKEY EGG WHITE LYSOZYME
B5G10H'CL, GAN-GLIO-SIDE AU-TOAN-TI-BODY  GAL-GALNAC BSA  3 FL BSA
Z122VH5'CL, CD20
HA-3'CL, ERY-THRO-CYTE
1-2'CL, IG-G2A
RF-IP9'CL, RHEUMA-TOID FAC-TOR
E11, MOUSE KAP-PA LIGHT CHAIN  P AZOPHENY-LAR-SON-ATE BSA  ARS BSA   ID-IO-TYPE
Ab2 A'CL, AU-TO ID-IO-TYP-IC DE-TER-MI-NANT  ID R  ON MAB 28 12
EL-25'CL, FAC-TOR VI-II
D10'CL, RH D
LAY, HU-MAN GAM-MA G1 AND G3 GLOB-U-LIN-S; PO ID-IO-TYPE
126TP7H'CL, THY-ROID PER-OX-I-DASE  TPO
II-481'CL, GE  THE HER-PES SIM-PLEX VIRUS 1 FCG BIND-ING PRO-TEIN
15E8'CL, CRYP-TO-COC-CUS NE-O-FOR-MANS  SEROP-TYPE A  GLU-CURONOXY-LO-MAN-NAN TETANUS TOX-OID CON-JU-GATE
LES-A'CL, RHEUMA-TOID FAC-TOR
N19-8 scFv'CL, HU-MAN COM-PLE-MENT C5 CON-VER-TASE
Jac-10'CL, ERY-THRO-CYTE RH D  AL-LOANTI-GEN
T10-421'CL, HLA A2 28 MAB CR11 351 COU-PLED TO KEY-HOLE LIMPET HEMO-CYANIN
SER'CL, AU-TOAN-TI-BODY
1G2'CL, MOUSE CY-TOCHROME C AROUND RESIDUE 62
CBLC235.7'CL, BAC-TE-RI-AL LEV-AN
C05'CL, RH D
C1'CL, BO-TULINUM NEU-RO-TOX-IN TYPE A BIND-ING DO-MAIN  BONT A HC
414.2'CL, B1335 DEX
AC38 251.5, AN-TI-BODY AC38 POS-I-TIVE HY-BRIDO-MA
6H-3C4'CL, HU-MAN SPERM IM-MO-BI-LIZ-ING AN-TI-BODY
D7'CL, THY-ROID PER-OX-I-DASE AU-TOAN-TI-BODY
LC4'CL, CD19
2INL10'CL, HU-MAN IN-SULIN
3B8G9'CL, TG
4C8'CL, MOUSE RED BLOOD CELL AU-TOAN-TI-BOD-IES
A1'CL, GLY-COPHORIN A
B43'CL, CD19
JV2'CL, IG-G1 MON-O-CLON-AL AU-TOAN-TI-BODY  RHEUMA-TOID FAC-TOR
ALN/16/53'CL, CHON-DROITIN SUL-PHATE PRO-TEO-GLY-CAN NG2  A TU-MOR SPE-CIF-IC ANTI-GEN ON THE 3 4 BEN-ZPYRENE IN-DUCED RAT CHON-DROSAR-CO-MA HSN
CBLC270.1'CL, BAC-TE-RI-AL LEV-AN
ALN/9/94'CL, CHON-DROITIN SUL-PHATE PRO-TEO-GLY-CAN NG2  A TU-MOR SPE-CIF-IC ANTI-GEN ON THE 3 4 BEN-ZPYRENE IN-DUCED RAT CHON-DROSAR-CO-MA HSN
10/8'CL, PRO-GES-TER-ONE HY-BRIDO-MA
CG-6'CL, ERY-THRO-CYTE
VL A30, CD34
Z18VH4'CL, CD20
Z112VH3'CL, CD20
10.2.3'CL, GROUP A STREP-TO-COC-CAL M PRO-TEIN  SKELE-TAL MYOSIN  CAR-DIAC MYOSIN  LIGHT MEROMYOSIN
A09, LYSOZYME HY-BRIDO-MA
39-A11, CAT-ALYT-IC AN-TI-BODY WHICH CATAL-Y-SES A DIELS ALDER RE-AC-TION
PE23'CL, HU-MAN PROENKEPHALIN  A NEU-ROPEP-TIDE PRE-CUR-SOR  PEP-TIDE 155DL-LKEL-L161
J02'CL, RH D
126TP8H'CL, THY-ROID PER-OX-I-DASE  TPO
6A7.E5'CL, RAT 62 CY-TOCHROME C
68.7, MYELIN OLIGO-DEN-DRO-CYTE GLY-CO-PRO-TEIN  MOG
HSCFV198, ACHR
417.F32.36'CL, MONORE-AC-TIVE
VL A47, CD34
5G5'CL, HU-MAN PRO-COL-LA-GE-NASE
18G9'CL, CRYP-TO-COC-CUS NE-O-FOR-MANS  SEROP-TYPE A  GLU-CURONOXY-LO-MAN-NAN TETANUS TOX-OID CON-JU-GATE
133'CL, KEY HOLE LIMPET HEMO-CYANIN COU-PLED AN-GIOTENSIN II
GN901v1.1, CD56
SIE, HU-MAN GAM-MA G GLOB-U-LIN; WA ID-IO-TYPE
C1'CL, GLY-COPHORIN A
3F9L'CL, MUR-INE SERUM AL-BU-MIN
126TO1H'CL, THY-ROID PER-OX-I-DASE  TPO
hsiggll295'CL, RAB-BIT IGG
N901L, CD56
WG2'CL, PRO-TEINASE 3
WRD2'CL, RHEUMA-TOID FAC-TOR
cDNA3-Hul'CL, IGG  RHEUMA-TOID FAC-TOR
PR-SJ1'CL, POLYRE-AC-TIVE RHEUMA-TOID FAC-TOR
mAb67'CL, POLYRE-AC-TIVE IGG FC FRAG-MENT RHEUMA-TOID FAC-TOR
7C5'CL, SM
F1_1354'CL, FRAC-TION 1
CDP571, RE-COM-BI-NANT HU-MAN TU-MOUR NECRO-SIS FAC-TOR AL-PHA
MRA1H'CL, HI-S-T-ONE
ARMVH'CL, MYELIN AS-SO-CI-AT-ED PRO-TEIN
8'CL, IN-SULIN
2.64'CL, PNEU-MO-COC-CAL
10F10'CL, CRYP-TO-COC-CUS NE-O-FOR-MANS  SEROP-TYPE A  GLU-CURONOXY-LO-MAN-NAN TETANUS TOX-OID CON-JU-GATE
E3'CL, AR-SON-ATE AN-TI-BODY HY-BRIDO-MA
TR1.32'CL, THY-ROID PER-OX-I-DASE AU-TOAN-TI-BODY
AF52, ID-IO-TYP-IC  I.E. E5.2  AN D1.3 WHICH IS HEN EGG LYSOZYME   WITH KA  FAB E5.2  = 2.4 X 10-EX-P7 M AND KA  HEN EGG LYSOZYME  = 3.8 X 10-EX-P6 M
LOC'CL, MYELIN AS-SO-CI-AT-ED GLY-CO-PRO-TEIN AND SUL-FAT-ED GLU-CURON-IC PARA-GLO-BO-SIDE
D115, MOUSE KAP-PA LIGHT CHAIN  P AZOPHENY-LAR-SON-ATE BSA  ARS BSA
F6-3'CL, TEPC15 ID-IO-TYPE AN-TI-BODY HY-BRIDO-MA
88.7, MYELIN OLIGO-DEN-DRO-CYTE GLY-CO-PRO-TEIN  MOG
N10'CL, STAPHY-LO-COC-CAL NU-CLE-ASE
SCFV198, ACHR
B003=46/2D7'CL, BLOOD GROUP B SUB-STANCE HY-BRIDO-MA
12-3-4'CL, ESE  EX-TRA SHEEP E ANTI-GEN
CLL'CL, IGG  RHEUMA-TOID FAC-TOR
VS3'CL, IG-G1 MON-O-CLON-AL AU-TOAN-TI-BODY  RHEUMA-TOID FAC-TOR
scF11, HU-MAN FER-RITIN
5E9''CL, SM HY-BRIDO-MA
POM, HU-MAN GAM-MA G1 GLOB-U-LIN; PO ID-IO-TYPE
C219'CL, P GLY-CO-PRO-TEIN
126JH'CL, THY-ROID PER-OX-I-DASE  TPO
BrM1'CL, E. COLI  BROME-LAIN TREAT-ED MOUSE RBC  TRIMETHY-LAM-MO-NI-UM HY-BRIDO-MA
C09, LYSOZYME HY-BRIDO-MA
DS1F8'CL, NAT-U-RAL AU-TO AN-TI-BODY RE-AC-TIVE WITH OLIGO-DEN-DRO-CYTE
MUSE11'CL, TAN-DEM RE-PEAT DO-MAIN OF MUCIN CORE PRO-TEIN MUC1
M25-9'CL, ACTIN  MYOSIN  TUBU-LIN  DS-D-NA  SS-D-NA AU-TOAN-TI-BODY  BIND-ING CON-TANTS RANGE BE-TWEEN 10-EX-P6 TO 10-EX-P8
126TP9H'CL, THY-ROID PER-OX-I-DASE  TPO
HN.14'CL, MYELIN AS-SO-CI-AT-ED GLY-CO-PRO-TEIN HY-BRIDO-MA
slkv11'CL, IGG POLY-CLON-AL RHEUMA-TOID FAC-TOR
AF5'CL, HU-MAN AL-PHA FE-TO-PRO-TEIN
LS5'CL, PR2 RBC AU-TOAN-TI-BODY
82B6a'CL, AU-TOAN-TI-BODY TO THY-ROGLOB-U-LIN
126TO2H'CL, THY-ROID PER-OX-I-DASE  TPO
56R-9'CL, 3M 1 TUBU-LAR BASE-MENT MEM-BRANE
1H12'CL, LAMININ RE-CEP-TOR OF STAPHY-LO-COC-CUS AU-REUS
S10P19'CL, RHEUMA-TOID FAC-TOR
PE17'CL, HU-MAN PROENKEPHALIN  A NEU-ROPEP-TIDE PRE-CUR-SOR  PEP-TIDE 155DL-LKEL-L161
PR-SJ2'CL, POLYRE-AC-TIVE RHEUMA-TOID FAC-TOR
L2 8C'CL, EPI-DER-MAL GROWTH FAC-TOR RE-CEP-TOR
9-12'CL, IG-G2A
HP12'CL, PRI-VATE ID-IO-TYPE HY-BRIDO-MA OF THE GAT SYS-TEM
MRA3K'CL, HI-S-T-ONE
L93'CL, HU-MAN CD4
LOI, COM-PLE-MENT FAC-TOR H  LIGHT CHAIN DIMER
L24'CL, AU-TOAN-TI-BODY
MIMA-8'CL, JS B+
IN-1'CL, MYELIN AS-SO-CI-AT-ED IN-HIBITORS OF NEU-RITE GROWTH
Mc3'CL, BA46  A 46 KDA GLY-CO-PRO-TEIN OF THE HU-MAN MILK FAT GLOB-ULE MEM-BRANE EX-PRESSED IN BREAST CAR-CI-NO-MA CELLS
9F9'CL, MOUSE CY-TOCHROME C AROUND RESIDUE 62
M2 87'CL, MOUSE TYPE II COL-LA-GEN
anti-Leu3a'CL, HU-MAN CD4
cAbAM07, AL-PHA AMY-LASE
ESC'CL, AU-TOAN-TI-BODY
ASWA3'CL, NU-CLE-O-LAR PAR-TI-CLES U3  U8 AND FIB-RIL-LAR-IN
53R-4'CL, 3M 1
22.94.4'CL, BALB C ID-IO-TYP-IC MON-O-CLON-AL AN-TI-BODY HP ID22 HY-BRIDO-MA
717'CL, P601E
C7'CL, HU-MAN IN-TER-FER-ON GAM-MA RE-CEP-TOR
2INL12'CL, HU-MAN IN-SULIN
BMA 031 VH'CL, HU-MAN TCR AL-PHA BE-TA
D31'CL, RH D
TR1.6'CL, THY-ROID PER-OX-I-DASE AU-TOAN-TI-BODY
10C9'CL, RE-ACTS WITH HU-MAN IG-G.
PD1'CL, CHRO-MATIN
C04, LYSOZYME HY-BRIDO-MA
scFv03, POLY-SPE-CIF-IC
4F5'CL, HU-MAN PRO-COL-LA-GE-NASE
N901L/KV4B, CD56
FOG1-G8'CL, HU-MAN MAB FOG 1  IG-G1 KAP-PA
RF-ET10'CL, RHEUMA-TOID FAC-TOR
F9A7'CL, ACTIN  MYOSIN  TUBU-LIN  DS-D-NA  SS-D-NA AU-TOAN-TI-BODY  BIND-ING CON-TANTS RANGE BE-TWEEN 10-EX-P6 TO 10-EX-P8
HA3D1'CL, RHEUMA-TOID FAC-TOR
105-2H'CL, MOUSE RED BLOOD CELL AU-TOAN-TI-BOD-IES
163.9, P53
HD37'CL, CD19
82H'CL, R585  A RAB-BIT TAX-OL AN-TI-BODY
E7'CL, POLYRE-AC-TIVE AU-TOAN-TI-BODY HY-BRIDO-MA
Fog-B'CL, D ANTI-GEN OF THE RH BLOOD GROUP SYS-TEM
N02'CL, RH D
HP29'CL, PUB-LIC ID-IOTOPE HY-BRIDO-MA OF THE GAT SYS-TEM
57R-1'CL, 3M 1 TUBU-LAR BASE-MENT MEM-BRANE
L2 11C'CL, EPI-DER-MAL GROWTH FAC-TOR RE-CEP-TOR
RF-FO2'CL, RHEUMA-TOID FAC-TOR
b'CL, ID-IO-TYPE  EX-PRESSED ON THE SUR-FACE OF NON HODGKIN S LYM-PHOMA CELLS
B7, MYELIN OLIGO-DEN-DRO-CYTE GLY-CO-PRO-TEIN  MOG
AD3/15'CL, ERY-THRO-CYTE RH D
B5G10K'CL, GAN-GLIO-SIDE AU-TOAN-TI-BODY  GAL-GALNAC BSA  3 FL BSA
GG3'CL, RHEUMA-TOID FAC-TOR
3C10'CL, FE-CAL BAC-TE-RIA
slkv12'CL, IGG POLY-CLON-AL RHEUMA-TOID FAC-TOR
RF-KES1'CL, RHEUMA-TOID FAC-TOR AU-TOAN-TI-BODY
12IIB6'CL, AU-TOAN-TI-BODY TO THY-ROGLOB-U-LIN
DM1'CL, KIM11.4
417.F14'CL, MONORE-AC-TIVE TO BE-TA GALAC-TOSI-DASE
126TO3H'CL, THY-ROID PER-OX-I-DASE  TPO
2E7'CL, PLATELET IN-TE-GRIN GPI-IB II-IA IIB HEAVY CHAIN  RES. 231 238
L37'CL, AU-TOAN-TI-BODY
mAb A41 kappa-1'CL, HU-MAN IN-TER-LEUKIN 2 RE-CEP-TOR BE-TA SUB-UNIT  P75
M74 (VH3-JH4)'CL, RHEUMA-TOID FAC-TOR
2INL13'CL, HU-MAN IN-SULIN
PE2'CL, HU-MAN PROENKEPHALIN  A NEU-ROPEP-TIDE PRE-CUR-SOR
CB 268'CL, HU-MAN AND MOUSE TYPE II COL-LA-GEN C1 EPI-TOPE  RESIDUES 316 TO 333
Ab3 CE5'CL, HU-MAN TU-MOR AS-SO-CI-AT-ED ANTI-GEN GA733
B12'CL, TG
4B4'CL, HU-MAN PRO-COL-LA-GE-NASE
mAb 124'CL, IN-SULIN
417.32.E4.8.5'CL, MONORE-AC-TIVE
CLONE 1D8'CL, HU-MAN RED BLOOD CELL
LAR'CL, RHEUMA-TOID FAC-TOR
SCH94.03'CL, SPEC-TRIN AU-TOAN-TI-BODY
MabA34'CL, HU-MAN PLAS-MA APOLIPOPRO-TEIN A 1
AC38 15.3, AN-TI-BODY AC38 POS-I-TIVE HY-BRIDO-MA
RF2-4'CL, IG-G2A
I05'CL, RH D
BBLC1.1'CL, BAC-TE-RI-AL LEV-AN
PAC1'CL, PLATELET FIB-RINO-GEN RE-CEP-TOR.
MBr1'CL, HU-MAN MAM-MA-RY CAR-CI-NO-MA LINE MCF 7 HY-BRIDO-MA
163.20, P53
Ab1 CO17-1A'CL, HU-MAN TU-MOR AS-SO-CI-AT-ED ANTI-GEN GA733
RF4-3FA'CL, IG-G1
slkv13'CL, IGG POLY-CLON-AL RHEUMA-TOID FAC-TOR
VH FUR1'CL, LAMIN B AU-TOAN-TI-BODY
hsighvl295'CL, RAB-BIT IGG
THY-23'CL, HU-MAN THY-ROGLOB-U-LIN
RF-TS7'CL, HU-MAN RAB-BIT IGG RHEUMA-TOID FAC-TOR
hu2.0, VAS-CU-LAR EN-DOTHE-LIAL GROWTH FAC-TOR
RF-FO3'CL, RHEUMA-TOID FAC-TOR
d'CL, ID-IO-TYPE  EX-PRESSED ON THE SUR-FACE OF NON HODGKIN S LYM-PHOMA CELLS
RF5-7'CL, IG-G2A
PE20'CL, HU-MAN PROENKEPHALIN  A NEU-ROPEP-TIDE PRE-CUR-SOR  PEP-TIDE 175GS-D-NEEEVSKR185
OVB3'CL, OVAR-I-AN CAN-CER CELLS
WIL'CL, RHEUMA-TOID FAC-TOR
MH6'CL, ACETYL-CHOLINE RE-CEP-TOR AU-TOAN-TI-BODY
m33N/D, ID-IO-TYP-IC
S/SB5-37'CL, H4
1F12'CL, HU-MAN PRO-COL-LA-GE-NASE
B11'CL, ID-IO-TYPE OF THE MUR-INE MAB RSV19
PAY, CRYO-GLOB-U-LIN WITH IGG AC-TIV-I-TY; B ID-IO-TYPE
RF-IP20'CL, RHEUMA-TOID FAC-TOR
MAL'CL, MYELIN AS-SO-CI-AT-ED GLY-CO-PRO-TEIN AND SUL-FAT-ED GLU-CURON-IC PARA-GLO-BO-SIDE
B'20 (VH3-JH4)'CL, RHEUMA-TOID FAC-TOR
FS-6'CL, COLD AG-GLU-TININ
3A3.C2'CL, HORSE 60 CY-TOCHROME C
10G9'CL, ID-IO-TYP-IC AN-TI-BODY TO THE MON-O-CLON-AL HALOPERI-DOL AN-TI-BODY WITH SPE-CIF-IC BIND-ING AFFIN-I-TY TO SIG-MA RE-CEP-TOR
2B12 (Dp2A)'CL, DER P 2  HOUSE DUST MITE AL-LER-GEN
PY102''CL, HEMAG-GLU-TININ OF PR8  H1N1  VIRUS
723569, TYPE VI-II PNEU-MO-COC-CAL POLY-SAC-CHA-RIDE
HA-VG'CL, ERY-THRO-CYTE
RF2-9'CL, IG-G2A
2INL14'CL, HU-MAN IN-SULIN
heavy2'CL, HU-MAN THY-ROGLOB-U-LIN
89'CL, AU-TO ID-IO-TYP-IC DE-TER-MI-NANT  ID R  ON MAB 28 12
2G5'CL, MOUSE CY-TOCHROME C AROUND RESIDUE 62
D08'CL, RH D
Meso 3, RE-COM-BI-NANT MESOTHE-LIN  MESOTHE-LIN POS-I-TIVE CELLS
HB125'CL, IN-SULIN
417.7.3.1'CL, POLYRE-AC-TIVE
3C3'CL, BO-TULINUM NEU-RO-TOX-IN TYPE A BIND-ING DO-MAIN  BONT A HC
K-25, TYPE III PNEU-MO-COC-CAL POLY-SAC-CHA-RIDE
126TO10H'CL, THY-ROID PER-OX-I-DASE  TPO
PE14'CL, HU-MAN PROENKEPHALIN  A NEU-ROPEP-TIDE PRE-CUR-SOR  PEP-TIDE 155DL-LKEL-L161
D03'CL, RH D
Ab18'CL, POLYRE-AC-TIVE AU-TOAN-TI-BODY
SS, RE-COM-BI-NANT MESOTHE-LIN
Fom-A'CL, ERY-THRO-CYTE RH D  AL-LOANTI-GEN
H142-3H5'CL, CA CB SITE OF IN-FLUEN-ZA VIRUS A PR 8 34 HEMAG-GLU-TININ  PR8 HA
GP-3'CL, ERY-THRO-CYTE
126GH'CL, THY-ROID PER-OX-I-DASE  TPO
Z116VH4'CL, CD20
TNF-A1'CL, HU-MAN TU-MOR NECRO-SIS FAC-TOR AL-PHA
HuVHLYS'CL, LYSOZYME HY-BRIDO-MA
AF14, ID-IO-TYP-IC  I.E. E5.2  AN D1.3 WHICH IS HEN EGG LYSOZYME   WITH KA  FAB E5.2  = 1.0 X 10-EX-P9 M AND KA  HEN EGG LYSOZYME  = 1.8 X 10-EX-P6 M
Vh REN'CL, CAR-DI-OLIPIN BE-TA 2 GLY-CO-PRO-TEIN I AU-TOAN-TI-BODY
MRK16'CL, MUL-TIDRUG TRANS-PORTER P GLY-CO-PRO-TEIN
slkv14'CL, IGG POLY-CLON-AL RHEUMA-TOID FAC-TOR
QC1'CL, CHRO-MATIN
3374, TYPE III PNEU-MO-COC-CAL POLY-SAC-CHA-RIDE
MP10'CL, HLA CLASS II  DR-B1*01 *09 *1001 *15 *16
anti-(cyd-1)'CL,  CYD 1
KAS, HU-MAN GAM-MA G GLOB-U-LIN; WA ID-IO-TYPE
f'CL, ID-IO-TYPE  EX-PRESSED ON THE SUR-FACE OF NON HODGKIN S LYM-PHOMA CELLS
4G12'CL, MA-LIG-NANT TU-MOR  BROAD SPECI-FICI-TY ES-PE-CIAL-LY FOR LUNG SQUA-MOUS CELL CAR-CI-NO-MA  HY-BRIDO-MA
ALN/12/88'CL, CHON-DROITIN SUL-PHATE PRO-TEO-GLY-CAN NG2  A TU-MOR SPE-CIF-IC ANTI-GEN ON THE 3 4 BEN-ZPYRENE IN-DUCED RAT CHON-DROSAR-CO-MA HSN
L3'CL, HEN EGG WHITE LYSOZYME
WAT'CL, RHEUMA-TOID FAC-TOR
BBLC107.5'CL, BAC-TE-RI-AL LEV-AN
H152-43B2'CL, CA CB SITE OF IN-FLUEN-ZA VIRUS A PR 8 34 HEMAG-GLU-TININ  PR8 HA
AZ-14'CL, CAT-ALYT-IC AN-TI-BODY
RF9-12'CL, IG-G2A
I13'CL, RH D
cAbCA10, CAR-BON-IC AN-HY-DRASE
1-12'CL, SM HY-BRIDO-MA
SO2'CL, AN-TI9 HLA DQ3
N901L/KOL, CD56
126IK'CL, THY-ROID PER-OX-I-DASE  TPO
UN34.11'CL, TC RBC
RF-MR27'CL, RHEUMA-TOID FAC-TOR
HYHEL-10, HEN EGG WHITE LYSOZYME
RF6-6A'CL, IG-G1
163.22, P53
2INH5'CL, HU-MAN IN-SULIN
heavy3'CL, HU-MAN THY-ROGLOB-U-LIN
BS-1, TYPE III PNEU-MO-COC-CAL POLY-SAC-CHA-RIDE
pMDABG2-4'CL, HEMAG-GLU-TININ
13F1'CL, CRYP-TO-COC-CUS NE-O-FOR-MANS  SEROP-TYPE A  GLU-CURONOXY-LO-MAN-NAN TETANUS TOX-OID CON-JU-GATE
H35-C10'CL, A PR 8 34 IN-FLUEN-ZA VIRUS HEMAG-GLU-TININ DI-RECT-ED TO THE CB SITE
126TO6H'CL, THY-ROID PER-OX-I-DASE  TPO
S2P10'CL, RHEUMA-TOID FAC-TOR
LN2 7'CL, MOUSE TYPE II COL-LA-GEN
hsiggll150'CL, RAB-BIT IGG
7B6''CL, SM HY-BRIDO-MA
RF-SJ1'CL, RHEUMA-TOID FAC-TOR AU-TOAN-TI-BODY
306'CL, IN-SULIN
60.3'CL, CD18
OX-34, RAT CD2
hu2.10, VAS-CU-LAR EN-DOTHE-LIAL GROWTH FAC-TOR
T10-352'CL, HLA A2 28 MAB CR11 351 COU-PLED TO KEY-HOLE LIMPET HEMO-CYANIN
mAb49'CL, IN-SULIN
VS3, IGG MON-O-CLON-AL AU-TOAN-TI-BODY  RHEUMA-TOID FAC-TOR
VH iv.'CL, GLU-TATHI-ONE S TRANS-FERASE
T10-440'CL, HLA A2 28 MAB CR11 351 COU-PLED TO KEY-HOLE LIMPET HEMO-CYANIN
14D2.D6'CL, RAT 62 CY-TOCHROME C
MF8 (Humkv328-Jk1)'CL, RHEUMA-TOID FAC-TOR
DPA'CL, GLU-TAM-IC ACID DE-CAR-BOXY-LASE 65
slkv15'CL, IGG POLY-CLON-AL RHEUMA-TOID FAC-TOR
C25'CL, BO-TULINUM NEU-RO-TOX-IN TYPE A BIND-ING DO-MAIN  BONT A HC  EPI-TOPE 2  KD = 1.1 X 10-EXP 9
10VA2'CL, AU-TOAN-TI-BODY TO THY-ROGLOB-U-LIN
scFv 1F9'CL, TURKEY EGG WHITE LYSOZYME
3T72, TYPE III PNEU-MO-COC-CAL POLY-SAC-CHA-RIDE
K1, MESOTHE-LIN
LG2-1'CL, BOV-INE THY-MUS HI-S-T-ONES  H3 RES. 30 45
13G12'CL, CRYP-TO-COC-CUS NE-O-FOR-MANS  SEROP-TYPE A  GLU-CURONOXY-LO-MAN-NAN TETANUS TOX-OID CON-JU-GATE
heavy4'CL, HU-MAN THY-ROGLOB-U-LIN
VH A121, CD34
3368, TYPE III PNEU-MO-COC-CAL POLY-SAC-CHA-RIDE
D16'CL, RH D
2INL1'CL, HU-MAN IN-SULIN
2F8.C10'CL, RAT 44 CY-TOCHROME C
R5A3H'CL, GAN-GLIO-SIDE AU-TOAN-TI-BODY  GA1
546'CL, P601E
H230-5'CL, A PR 8 34 IN-FLUEN-ZA VIRUS HEMAG-GLU-TININ DI-RECT-ED TO THE CB SITE
LA1L1'CL, RHEUMA-TOID FAC-TOR
M56'CL, SMITH ANTI-GEN HY-BRIDO-MA
FV-BETA, HCG
Z55VH3'CL, CD20
24.7, MYELIN OLIGO-DEN-DRO-CYTE GLY-CO-PRO-TEIN  MOG
bkv32'CL, IGG POLY-CLON-AL RHEUMA-TOID FAC-TOR
H147-25H1'CL, A PR 8 34 IN-FLUEN-ZA VIRUS HEMAG-GLU-TININ DI-RECT-ED TO THE CB SITE
D11'CL, RH D
CP4 9-9'CL, BROME-LAIN TREAT-ED MOUSE RED BLOOD CELL HY-BRIDO-MA
MRA12H'CL, HI-S-T-ONE
MRL-Histone7'CL, HI-S-T-ONE 2A 4 HY-BRIDO-MA
2INL16'CL, HU-MAN IN-SULIN
RF-IP18'CL, RHEUMA-TOID FAC-TOR
TR1.37'CL, THY-ROID PER-OX-I-DASE AU-TOAN-TI-BODY
CBLC213.7'CL, BAC-TE-RI-AL LEV-AN
CL-P'CL, ERY-THRO-CYTE
BBLC44.1'CL, BAC-TE-RI-AL LEV-AN
hsiglvp1213'CL, RAB-BIT IGG
301'CL, IN-SULIN
RC1H, LOW AFFIN-I-TY POLYRE-AC-TIVE  FC TETANUS TOX-OID RAB-BIT IGG  SS-D-NA  RHEUMA-TOID FAC-TOR  RF
4A6 Fab'CL, RE-COM-BI-NANT BIRCH PRO-FIL-IN
#21'CL, LA RNP  RI-BONU-CLE-O-PRO-TEIN
E66, MOUSE KAP-PA LIGHT CHAIN  P AZOPHENY-LAR-SON-ATE BSA  ARS BSA   ID-IO-TYPE
A26'CL, IG-G1 MON-O-CLON-AL AU-TOAN-TI-BODY  RHEUMA-TOID FAC-TOR
G21'CL, THE AU-THORS ES-TI-MAT-ED THAT THERE ARE ABOUT 0.2 0.5% OF PE-RIPH-ER-AL BLOOD B LYM-PHO-CYTES WHICH ARE KAP-PA + AND LAMB-DA +.
2E11'CL, CAT-ALYT-IC AN-TI-BODY
JV8'CL, IG-G1 MON-O-CLON-AL AU-TOAN-TI-BODY  RHEUMA-TOID FAC-TOR
MRB4'CL, NU-CLE-O-SOME
RF-SJ2'CL, RHEUMA-TOID FAC-TOR AU-TOAN-TI-BODY
CBGA1'CL, POLY RE-AC-TIVE IN-CLUD-ING PSEU-DOMONAS AERUG-I-NOSA PA C7 67  ES-CHERICHIA COLI O1Z  ERY-THRO-CYTES FROM DONOR  ETC.
RB4v1.2, CD19
9E10'CL, C MYC
AC41'CL, HU-MAN CY-TOMEGALO-VIRUS  CMV  MEM-BRANE GLY-CO-PRO-TEIN GP58 116  GB  AD2 EPI-TOPE  RESIDUES 67 TO 86 OF GP116
BrM8'CL, E. COLI  BROME-LAIN TREAT-ED MOUSE RBC  TRIMETHY-LAM-MO-NI-UM HY-BRIDO-MA
FS-3'CL, COLD AG-GLU-TININ
E225'CL, D1.3 MAB
IM9, HU-MAN CAR-CI-NOEM-BRY-ON-IC ANTI-GEN
48.2.1'CL, ID-IO-TYP-IC AN-TI-BODY
B27'CL, B2 GLY-CO-PRO-TEIN 1  KD = 1.5 X 10-EXP 6
H140-1E6'CL, CA CB SITE OF IN-FLUEN-ZA VIRUS A PR 8 34 HEMAG-GLU-TININ  PR8 HA
Ab21'CL, POLYRE-AC-TIVE AU-TOAN-TI-BODY
slkv16'CL, IGG POLY-CLON-AL RHEUMA-TOID FAC-TOR
mAb A41'CL, HU-MAN IN-TER-LEUKIN 2 RE-CEP-TOR BE-TA SUB-UNIT  P75
heavy5'CL, HU-MAN THY-ROGLOB-U-LIN
RF-5'CL, IG-G1 RHEUMA-TOID FAC-TOR
CP4 12-18'CL, BROME-LAIN TREAT-ED MOUSE RED BLOOD CELL HY-BRIDO-MA
10/14'CL, MON-O-CLON-AL AN-TI-ID-IO-TYP-IC AN-TI-BODY IDA10 HY-BRIDO-MA
L17'CL, AU-TOAN-TI-BODY
208,D-5, P1.7 PO-RA PRO-TEIN LOOP OF NEIS-SE-RIA MENIN-GI-TIDIS
MAB61'CL, KIM11.4
1G3.E3'CL, COW 44 CY-TOCHROME C
SP2'CL, HU-MAN THY-ROID PER-OX-I-DASE
lambda5'CL, HU-MAN THY-ROGLOB-U-LIN
HuVK'CL, HU-MAN HIGH BIND-ING AFFIN-I-TY RE-CEP-TOR FOR FC OF IGG  FC-GRI
112'CL, HET-ERO-HY-BRIDO-MA AN-TI-BODY TO LYM-PHOMA CELLS POS-SESS-ING ID-IOTOPE RE-ACT-ING WITH ID-IO-TYPE 7D11 AF-TER TREAT-MENT WITH 7D11.
BBLC259.11'CL, BAC-TE-RI-AL LEV-AN
ASWA2'CL, NU-CLE-O-LAR PAR-TI-CLES U3  U8
KJ16'CL, TCR VB8.1 & VB8.2
HA-7'CL, ERY-THRO-CYTE
JV3'CL, IG-G1 MON-O-CLON-AL AU-TOAN-TI-BODY  RHEUMA-TOID FAC-TOR
RF-SJ3'CL, RHEUMA-TOID FAC-TOR AU-TOAN-TI-BODY
S25'CL, BO-TULINUM NEU-RO-TOX-IN TYPE A BIND-ING DO-MAIN  BONT A HC  EPI-TOPE 1  KD = 7.3 X 10-EXP 8
126DH'CL, THY-ROID PER-OX-I-DASE  TPO
s6C9'CL, CAR-DI-OLIPIN AU-TOAN-TI-BODY
126.33'CL, B1335 DEX
S2-14.2'CL, TC RBC
M2 136'CL, MOUSE TYPE II COL-LA-GEN
CE10G11G2'CL, P34
TB-1-P5'CL, RHEUMA-TOID FAC-TOR
16E4'CL, CRYP-TO-COC-CUS NE-O-FOR-MANS  SEROP-TYPE A  GLU-CURONOXY-LO-MAN-NAN TETANUS TOX-OID CON-JU-GATE
TR1.21'CL, THY-ROID PER-OX-I-DASE AU-TOAN-TI-BODY
D3'CL, THY-ROID PER-OX-I-DASE AU-TOAN-TI-BODY
26C1'CL, RH D
126TO8H'CL, THY-ROID PER-OX-I-DASE  TPO
4A11'CL, P601E
L2,5'CL, HEN EGG WHITE LYSOZYME
T8-3'CL, T3 EPI-TOPE  GLY 225  OF IN-FLUEN-ZA VIRUS HEMAG-GLU-TININ
BBLC508.17'CL, BAC-TE-RI-AL LEV-AN
C01'CL, RH D
GB4v2.3, CD19
431'CL, P601E
T8-203'CL, HLA A2 28 MAB CR11 351 COU-PLED TO KEY-HOLE LIMPET HEMO-CYANIN
Pag-1'CL, D ANTI-GEN OF THE RH BLOOD GROUP SYS-TEM
CB 379'CL, HU-MAN AND MOUSE TYPE II COL-LA-GEN C1 EPI-TOPE  RESIDUES 316 TO 333
cDNA2-Hul'CL, IGG  RHEUMA-TOID FAC-TOR
HYHEL-8, HEN EGG WHITE LYSOZYME
mAb 133'CL, IN-SULIN
H20C3K'CL, GAN-GLIO-SIDE AU-TOAN-TI-BODY  GAL-GALNAC BSA  3 FL BSA
WG3'CL, PRO-TEINASE 3
126FK'CL, THY-ROID PER-OX-I-DASE  TPO
HUL-GL'CL, IGG  RHEUMA-TOID FAC-TOR
18.3, MYELIN OLIGO-DEN-DRO-CYTE GLY-CO-PRO-TEIN  MOG
L11-2E2'CL, A PR 8 34 IN-FLUEN-ZA VIRUS HEMAG-GLU-TININ DI-RECT-ED TO THE CB SITE
417.F33.3'CL, MONORE-AC-TIVE
TR1.22'CL, THY-ROID PER-OX-I-DASE AU-TOAN-TI-BODY
5-3'CL, IG-G2A
126TO9H'CL, THY-ROID PER-OX-I-DASE  TPO
F1_1471'CL, FRAC-TION 1
TEL9'CL, TURKEY EGG WHITE LYSOZYME
CLONE 1C4'CL, HU-MAN RED BLOOD CELL
m62N/D, ID-IO-TYP-IC
KOL-based resh. CAMPATH-9, HU-MAN CD4
A4, DI-HY-DROFLAVONOL 4 RE-DUC-TASE FROM PETU-NIA HY-BRI-DA
L03'CL, RH D
22F6'CL, SM HY-BRIDO-MA
C595,  MUC1 MUCIN
CB 313'CL, HU-MAN AND MOUSE TYPE II COL-LA-GEN C1 EPI-TOPE  RESIDUES 316 TO 333
417.F25'CL, POLYRE-AC-TIVE
1B6'CL, BO-TULINUM NEU-RO-TOX-IN TYPE A BIND-ING DO-MAIN  BONT A HC
PR1A3, CELL BOUND CAR-CI-NOEM-BRY-ON-IC ANTI-GEN
LS6'CL, PR2 RBC AU-TOAN-TI-BODY
8H9D4'CL, PLAS-MINO-GEN AC-TI-VA-TOR IN-HIBITOR 1  BY SWITCH-ING THE IN-HIBITO-RY CON-FOR-MA-TION TO A SUB-STRATE CON-FOR-MA-TION
HuMAb22-13'CL, LUNG TU-MOR AS-SO-CI-AT-ED ANTI-GEN
RF-KES'CL, MONORE-AC-TIVE RHEUMA-TOID FAC-TOR
m32,33, ID-IO-TYP-IC
1D7'CL, HU-MAN APOLIPOPRO-TEIN E  SPE-CIF-IC FOR THE LOW DEN-SI-TY LIPOPRO-TEIN RE-CEP-TOR BIND-ING SITE
28/12'CL, AU-TO ID-IO-TYP-IC DE-TER-MI-NANT  ID R  ON MAB 28 12
F1_1254'CL, FRAC-TION 1
VS4'CL, IG-G1 MON-O-CLON-AL AU-TOAN-TI-BODY  RHEUMA-TOID FAC-TOR
VH A47, CD34
K.Kpb1'CL, KP B
VH A30, CD34
RF1-7K'CL, IG-G1
H02, LYSOZYME HY-BRIDO-MA
C11'CL, HU-MAN PARATHY-ROID HOR-M-ONE RE-LAT-ED PRO-TEIN RESIDUES 1 TO 34  KA=5.8X10-EX-P8
M37GO37'CL, E2 COM-P-O-NENT OF 2 OX-OG-LU-TARATE DE-HY-DRO-GE-NASE COM-PLEX
5E4'CL, CRYP-TO-COC-CUS NE-O-FOR-MANS  SEROP-TYPE A  GLU-CURONOXY-LO-MAN-NAN TETANUS TOX-OID CON-JU-GATE
A003=40/5G7'CL, BLOOD GROUP A SUB-STANCE HY-BRIDO-MA
7E10'CL, SM HY-BRIDO-MA
TR1.23'CL, THY-ROID PER-OX-I-DASE AU-TOAN-TI-BODY
A34'CL, IG-G1 MON-O-CLON-AL AU-TOAN-TI-BODY  RHEUMA-TOID FAC-TOR
TR1.5'CL, THY-ROID PER-OX-I-DASE AU-TOAN-TI-BODY
WRD6'CL, RHEUMA-TOID FAC-TOR
LS1'CL, PR2 RBC AU-TOAN-TI-BODY
F29'CL, THE AU-THORS ES-TI-MAT-ED THAT THERE ARE ABOUT 0.2 0.5% OF PE-RIPH-ER-AL BLOOD B LYM-PHO-CYTES WHICH ARE KAP-PA + AND LAMB-DA +.
E01'CL, RH D
CLONE 1F7'CL, HU-MAN RED BLOOD CELL
VL G61'CL, GLU-TATHI-ONE S TRANS-FERASE
418.F63.35'CL, POLYRE-AC-TIVE
MR-1'CL, MUR-INE GP39
MRA5H'CL, HI-S-T-ONE
C05, LYSOZYME HY-BRIDO-MA
UN42.5'CL, TC RBC
N901L/KV2F, CD56
MRA12K'CL, HI-S-T-ONE
3-31'CL, SM HY-BRIDO-MA
4.16.1'CL, MOUSE ERY-THRO-CYTE AU-TOAN-TI-BODY
1G5'CL, BO-TULINUM NEU-RO-TOX-IN TYPE A BIND-ING DO-MAIN  BONT A HC
E38, MOUSE KAP-PA LIGHT CHAIN  P AZOPHENY-LAR-SON-ATE BSA  ARS BSA   ID-IO-TYPE
WEI', CRYO-GLOB-U-LIN WITH LOW DEN-SI-TY LIPOPRO-TEIN AC-TIV-I-TY; B ID-IO-TYPE
E225, D1.3 HY-BRIDO-MA
THY-29'CL, HU-MAN THY-ROGLOB-U-LIN
CP5 B5-3'CL, BROME-LAIN TREAT-ED MOUSE RED BLOOD CELL HY-BRIDO-MA
H37-40'CL, IN-FLUEN-ZA VIRUS HEMAG-GLU-TININ HY-BRIDO-MA
alpha-poxn2, POXN
L1'CL, HEN EGG WHITE LYSOZYME
HUMANIZED YFC51.1'CL, HU-MAN CD18
3C8H'CL, MUR-INE SERUM AL-BU-MIN
TUR, COLD AG-GLU-TININ WITH PR AC-TIV-I-TY
D10, MOUSE KAP-PA LIGHT CHAIN  P AZOPHENY-LAR-SON-ATE BSA  ARS BSA   ID-IO-TYPE
31-9D'CL, MOUSE RED BLOOD CELL AU-TOAN-TI-BOD-IES
scFv-KJ16 mut4'CL, T CELL RE-CEP-TOR  V BE-TA8 RE-GION
Hb-4, FOETAL HAEMOGLOBIN  HBF
G01'CL, RH D
17F12'CL, HU-MAN IGG
2.7.1G.10'CL, CAR-CI-NOEM-BRY-ON-IC ANTI-GEN HY-BRIDO-MA
1E6'CL, HU-MAN PRO-COL-LA-GE-NASE
2677.1'CL, BAC-TE-RI-AL LEV-AN
JV10'CL, IG-G1 MON-O-CLON-AL AU-TOAN-TI-BODY  RHEUMA-TOID FAC-TOR
F1_1352'CL, FRAC-TION 1
TB-2-H70'CL, RHEUMA-TOID FAC-TOR
333'CL, HET-ERO-HY-BRIDO-MA AN-TI-BODY TO LYM-PHOMA CELLS POS-SESS-ING ID-IOTOPE RE-ACT-ING WITH ID-IO-TYPE 7D11 BE-FORE TREAT-MENT WITH 7D11.
Y19-10'CL, IGG HY-BRIDO-MA
C2'CL, THY-ROID PER-OX-I-DASE AU-TOAN-TI-BODY
AD9'CL, ERY-THRO-CYTE RH D
I06'CL, RH D
D3'CL, MOUSE TYPE II COL-LA-GEN
RF6-2'CL, IG-G2A
9F12Fab'CL, TETANUS TOX-IN
T10-505'CL, HLA A2 28 MAB CR11 351 COU-PLED TO KEY-HOLE LIMPET HEMO-CYANIN
MP14'CL, HLA CLASS II  DR-B1*08 *12
3D7.2'CL, CHRO-MATIN
Resurfaced Anti-B4, CD19
E8'CL, HORSE CY-TOCHROME C
RF10-2'CL, IG-G2A
alphaGPIIIa leu 33'CL, LEUC-INE 33 FORM OF PLATELET GLY-CO-PRO-TEIN II-IA
MRA7K'CL, HI-S-T-ONE
GOL', HU-MAN MON-O-CLON-AL AN-TI-BODY WITH WA ID-IO-TYPE
RF9-5'CL, IG-G2A
Fom-1'CL, ERY-THRO-CYTE RH D  AL-LOANTI-GEN
126AH'CL, THY-ROID PER-OX-I-DASE  TPO
MP6'CL, HLA CLASS I  A*3002
clone 14'CL, TIM-O-THY GRASS POLLEN MA-JOR AL-LER-GEN PHI P 5
M2 139'CL, MOUSE TYPE II COL-LA-GEN
RF1-7M'CL, IG-G1
AC32'CL, HU-MAN CY-TOMEGALO-VIRUS  CMV  MEM-BRANE GLY-CO-PRO-TEIN GP58 116  GB  AD2 EPI-TOPE  RESIDUES 67 TO 86 OF GP116
LUNm01'CL, CLASS 5C OUT-ER MEM-BRANE PRO-TEIN OF NEIS-SE-RIA MENIN-GI-TIDIS
B12'CL, ID-IO-TYPE OF THE MUR-INE MAB RSV19
126CK'CL, THY-ROID PER-OX-I-DASE  TPO
CLONE 1C9'CL, HU-MAN RED BLOOD CELL
MSL5, LEWIS Y
3-69'CL, SM HY-BRIDO-MA
9-3'CL, IG-G2A
73.7, MYELIN OLIGO-DEN-DRO-CYTE GLY-CO-PRO-TEIN  MOG
L33'CL, AU-TOAN-TI-BODY
CG-7'CL, ERY-THRO-CYTE
1E8'CL, MOUSE CY-TOCHROME C AROUND RESIDUE 62
22.218.1'CL, BALB C ID-IO-TYP-IC MON-O-CLON-AL AN-TI-BODY HP ID22 HY-BRIDO-MA
RF1-2'CL, IG-G2A
Z30VH3'CL, CD20
HA-4'CL, ERY-THRO-CYTE
I01'CL, RH D
ATM-2, TCR VBE-TA
2C3'CL, HU-MAN PRO-COL-LA-GE-NASE
LN2 97'CL, MOUSE TYPE II COL-LA-GEN
106-10E'CL, MOUSE RED BLOOD CELL AU-TOAN-TI-BOD-IES
AC7'CL, RGD  ARG GLY ASP  BIND-ING SITE ON THE GPI-I-IA SUB-UNIT OF THE PLATELET FIB-RINO-GEN RE-CEP-TOR  THE GPI-IB GPI-I-IA COM-PLEX
MRL-RF24'CL, IG-G1 2A 3 HY-BRIDO-MA
RF3-4'CL, IG-G2A
ANTI-LEU3a'CL, HU-MAN CD4
HIG1, ACHR
HP20'CL, PUB-LIC ID-IOTOPE HY-BRIDO-MA OF THE GAT SYS-TEM
WR1.107'CL, THY-ROID PER-OX-I-DASE
22'CL, IN-SULIN
F5-1336'CL, ID-IO-TYP-IC AN-TI-BODY AGAINST HLA DR1 4 W14 W8 9 MAB AC1.59 COU-PLED WITH KEY-HOLE LIMPET HEMO-CYANIN
lambda4'CL, HU-MAN THY-ROGLOB-U-LIN
18'CL, P601E
PE24'CL, HU-MAN PROENKEPHALIN  A NEU-ROPEP-TIDE PRE-CUR-SOR  PEP-TIDE 175GS-D-NEEEVSKR185
131TP2H'CL, THY-ROID PER-OX-I-DASE  TPO
98QQ'CL, 3 5 3  TRI-IO-DO L THRY-RO-N-INE COU-PLED KEY-HOLE LIMPET HEMO-CYANIN
My10, HU-MAN CD34  KD = 2.4 X 10-EXP 7 M
126TO10K'CL, THY-ROID PER-OX-I-DASE  TPO
2H12'CL, MOUSE CY-TOCHROME C AROUND RESIDUE 62
slkv4'CL, IGG POLY-CLON-AL RHEUMA-TOID FAC-TOR
3-19'CL, SM HY-BRIDO-MA
DPK24, P53
D09'CL, RH D
hsiglvl295'CL, RAB-BIT IGG
G05, LYSOZYME HY-BRIDO-MA
SON, CRYO-GLOB-U-LIN WITH LOW DEN-SI-TY LIPOPRO-TEIN AC-TIV-I-TY; B ID-IO-TYPE
147'CL, P601E
RF-KL1'CL, RHEUMA-TOID FAC-TOR AU-TOAN-TI-BODY
slkv9'CL, IGG POLY-CLON-AL RHEUMA-TOID FAC-TOR
E14, MOUSE KAP-PA LIGHT CHAIN  P AZOPHENY-LAR-SON-ATE BSA  ARS BSA
PA4'CL, CHRO-MATIN
2-4'CL, SM HY-BRIDO-MA
D2'CL, ID-IO-TYP-IC AN-TI-BODY AGAINST THE THY-ROTROPIN  TSH  RE-CEP-TOR
B/SB5-7'CL, H2A H2B
AP1'CL, GLY-COPHORIN A
TB-3-D13'CL, RHEUMA-TOID FAC-TOR
G4, DI-HY-DROFLAVONOL 4 RE-DUC-TASE FROM PETU-NIA HY-BRI-DA
JAC-1, POLYAM-INE  CROSS RE-ACTS WITH SPER-MINE
24'CL, LE X  SIA-LYL LE X
FOG1-H6'CL, HU-MAN MAB FOG 1  IG-G1 KAP-PA
COF'CL, RHEUMA-TOID FAC-TOR
Z48VH3'CL, CD20
6E5'CL, EAR-LY NU-CLE-O-SOME AU-TOAN-TI-BODY  KD = 1X10-EXP 8
D04'CL, RH D
3.14.9'CL, LEV-AN
IM9-2, HU-MAN CAR-CI-NOEM-BRY-ON-IC ANTI-GEN
PE1'CL, HU-MAN PROENKEPHALIN  A NEU-ROPEP-TIDE PRE-CUR-SOR  PEP-TIDE 187G-GFM-RG192
E4-14'CL, CON A
RF-1''CL, IG-G3 RHEUMA-TOID FAC-TOR
pVCM(VD93)'CL, PSEU-DOMONAS AERUG-I-NOSA HY-BRIDO-MA
93.7, MYELIN OLIGO-DEN-DRO-CYTE GLY-CO-PRO-TEIN  MOG
G6, MESOTHE-LIN
A4'CL, GLY-COPHORIN A
K01'CL, RH D
TNF-E1'CL, HU-MAN TU-MOR NECRO-SIS FAC-TOR AL-PHA
HA-10'CL, ERY-THRO-CYTE
HUMHA4114'CL, KIM11.4
B22'CL, B2 GLY-CO-PRO-TEIN 1  KD = 6.0 X 10-EXP 5
VL G64'CL, GLU-TATHI-ONE S TRANS-FERASE
mAb 127'CL, IN-SULIN HY-BRIDO-MA
T6-416'CL, T3 EPI-TOPE  GLY 225  OF IN-FLUEN-ZA VIRUS HEMAG-GLU-TININ
17-1A'CL, SW1083 COL-OREC-TAL CAR-CI-NO-MA CELL HY-BRIDO-MA
H36-2'CL, IN-FLUEN-ZA VIRUS HEMAG-GLU-TININ HY-BRIDO-MA
C2'CL, MOUSE TYPE II COL-LA-GEN
F5-444'CL, ID-IO-TYP-IC AN-TI-BODY AGAINST HLA DR1 4 W14 W8 9 MAB AC1.59 COU-PLED WITH KEY-HOLE LIMPET HEMO-CYANIN
AC38 205.12, AN-TI-BODY AC38 POS-I-TIVE HY-BRIDO-MA
RF3-2CR2A'CL, IG-G2A
F28C4'CL, MYE-LINE BA-SIC PRO-TEIN  ACETYL RESIDUES 1 9
AC-1001'CL, BLOOD GROUP A SUB-STANCE HY-BRIDO-MA
Z97VH3'CL, CD20
FOG1-A4'CL, HU-MAN MAB FOG 1  IG-G1 KAP-PA
mAb10'CL, POLYRE-AC-TIVE AU-TOAN-TI-BODY
H37-43'CL, IN-FLUEN-ZA VIRUS HEMAG-GLU-TININ HY-BRIDO-MA
5D9'CL, PI-GEON CY-TOCHROME C AND MOUSE CY-TOCHROME C
2INH4'CL, HU-MAN IN-SULIN
mAb48'CL, IN-SULIN
E63, MOUSE KAP-PA LIGHT CHAIN  P AZOPHENY-LAR-SON-ATE BSA  ARS BSA
HA-5'CL, IGG  NO ERY-THRO-CYTE AC-TIV-I-TY
RF-TT1'CL, RHEUMA-TOID FAC-TOR
PE18'CL, HU-MAN PROENKEPHALIN  A NEU-ROPEP-TIDE PRE-CUR-SOR  PEP-TIDE 155DL-LKEL-L161
Hb-1, FOETAL HAEMOGLOBIN  HBF
2BBLC403.4'CL, BAC-TE-RI-AL LEV-AN
K20'CL, BE-TA 1 CHAIN OF HU-MAN IN-TE-GRIN
FV/IL-2'CL, TAG72
F4-23'CL, CON A
B03, LYSOZYME HY-BRIDO-MA
L41'CL, AU-TOAN-TI-BODY
RA-4-Pd2'CL, RHEUMA-TOID FAC-TOR
2-11'CL, SM HY-BRIDO-MA
R6B8H'CL, GAN-GLIO-SIDE AU-TOAN-TI-BODY  GA1
5E1'CL, HU-MAN PRO-COL-LA-GE-NASE
CL-J'CL, ERY-THRO-CYTE
M16'CL, HU-MAN IN-SULIN
A28A'CL, IG-G2A
mAb61'CL, MONORE-AC-TIVE IGG FC FRAG-MENT RHEUMA-TOID FAC-TOR
126TP15H'CL, THY-ROID PER-OX-I-DASE  TPO
RF-2 PAN'CL, IGG PAN RHEUMA-TOID FAC-TOR
37-77'CL, IN-FLUEN-ZA VIRUS  A PR 8 34  HEMAG-GLU-TININ
M-T151'CL, HU-MAN CD4
D08, LYSOZYME HY-BRIDO-MA
TB-3-D6'CL, RHEUMA-TOID FAC-TOR
B'20H, POLYRE-AC-TIVE  HIGH AFFIN-I-TY HU-MAN FC AND LOW AFFIN-I-TY RAB-BIT IGG  SS-D-NA  TETANUS TOX-OID  RHEUMA-TOID FAC-TOR  RF
clone 1,3-12'CL, F AB  2 AU-TOAN-TI-BODY  BIND-ING CON-STAN-T=2.8X10-EX-P7
IC5-2A6'CL, IN-FLUEN-ZA VIRUS  A PR 8 34  HEMAG-GLU-TININ SEC-ONDARY AN-TI-BOD-IES  SB  HY-BRIDO-MA
Ab2022'CL, IN-SULIN AU-TOAN-TI-BODY
25G05, LYSOZYME HY-BRIDO-MA
1-9'CL, IG-G2A
4-35-7'CL, HLA A1  A23 AND A24
cAbAMB10, AL-PHA AMY-LASE
E13'CL, MELANOMA
H81'CL, LAMININ
LL2'CL, CD22  A SUR-FACE MOLECULE PRESENT ON B CELL LYM-PHOMA
302'CL, IN-SULIN
DPB'CL, GLU-TAM-IC ACID DE-CAR-BOXY-LASE 65
D2'CL, HU-MAN IN-TER-FER-ON GAM-MA RE-CEP-TOR
CB 300'CL, HU-MAN AND MOUSE TYPE II COL-LA-GEN C1 EPI-TOPE  RESIDUES 316 TO 333
D17'CL, RH D
MRA11H'CL, HI-S-T-ONE
B/SB5-33'CL, H2A H2B
cAb-Lys3, LYSOZYME
BS-5, TYPE III PNEU-MO-COC-CAL POLY-SAC-CHA-RIDE
C9'CL, THY-ROID PER-OX-I-DASE AU-TOAN-TI-BODY
TR1.10'CL, THY-ROID PER-OX-I-DASE AU-TOAN-TI-BODY
RF51'CL, IG-G1 MON-O-CLON-AL AU-TOAN-TI-BODY  RHEUMA-TOID FAC-TOR
HA-1'CL, ERY-THRO-CYTE
S/SB5-84'CL, H4
A1'CL, HU-MAN IN-TER-FER-ON GAM-MA RE-CEP-TOR
AH7'CL, HU-MAN N BLOOD GROUP ANTI-GEN
B4.13.2'CL, MOUSE ERY-THRO-CYTE AU-TOAN-TI-BODY
JV9'CL, IG-G1 MON-O-CLON-AL AU-TOAN-TI-BODY  RHEUMA-TOID FAC-TOR
S1P1'CL, RHEUMA-TOID FAC-TOR
cAbAMD9, AL-PHA AMY-LASE
RF10-4K'CL, IG-G2A
alpha-poxn4, POXN
VHTF'CL, PORC-INE TRANS-FER-RIN
mH-M, ID-IO-TYP-IC
B/SB5-37'CL, H4
H 113'CL, HU-MAN AND MOUSE TYPE II COL-LA-GEN C1 EPI-TOPE  RESIDUES 316 TO 333
Hu PR1A3, CELL BOUND CAR-CI-NOEM-BRY-ON-IC ANTI-GEN
O01'CL, RH D
A12', LYSOZYME HY-BRIDO-MA
GAR', CRYO-GLOB-U-LIN WITH IGG AC-TIV-I-TY; B ID-IO-TYPE
18R.136.1'CL, CAT-ALYT-IC AN-TI-BODY
TT125'CL, TETANUS TOX-IN  TOX-OID AND A FRAG-MENT  LIGHT CHAIN  OF TETANUS TOX-IN
RF-TS5'CL, MONORE-AC-TIVE RHEUMA-TOID FAC-TOR
2D9H'CL, MUR-INE SERUM AL-BU-MIN
K1 like, MESOTHE-LIN POS-I-TIVE CELLS
BOR', HU-MAN GAM-MA G GLOB-U-LIN; WA ID-IO-TYPE
LN2 173'CL, MOUSE TYPE II COL-LA-GEN
JV4'CL, IG-G1 MON-O-CLON-AL AU-TOAN-TI-BODY  RHEUMA-TOID FAC-TOR
3A10'CL, P601E
B9601 (Vg-Jk2)'CL, RHEUMA-TOID FAC-TOR
H3, DI-HY-DROFLAVONOL 4 RE-DUC-TASE FROM PETU-NIA HY-BRI-DA
Jel42'CL, ES-CHERICHIA COLI HIS-TI-D-INE CON-TAIN-ING PRO-TEIN  HPR
131TP5H'CL, THY-ROID PER-OX-I-DASE  TPO
2E8'CL, HU-MAN APOLIPOPRO-TEIN E  SPE-CIF-IC FOR THE LOW DEN-SI-TY LIPOPRO-TEIN RE-CEP-TOR BIND-ING SITE
RF-TT3'CL, RHEUMA-TOID FAC-TOR
cAbAM04, AL-PHA AMY-LASE
H220-10'CL, A PR 8 34 IN-FLUEN-ZA VIRUS HEMAG-GLU-TININ DI-RECT-ED TO THE CB SITE
L3G11'CL, CAR-DI-OLIPIN AU-TOAN-TI-BODY
IC5-4F4'CL, CA CB SITE OF IN-FLUEN-ZA VIRUS A PR 8 34 HEMAG-GLU-TININ  PR8 HA
H17-L19'CL, CA CB SITE OF IN-FLUEN-ZA VIRUS A PR 8 34 HEMAG-GLU-TININ  PR8 HA
BrE-3'CL, HU-MAN BREAST EP-ITHE-LIAL MUCIN
E67, MOUSE KAP-PA LIGHT CHAIN  P AZOPHENY-LAR-SON-ATE BSA  ARS BSA   ID-IO-TYPE
Mik-B1(Fv)-PE40'CL, IN-TER-LEUKIN 2 RE-CEP-TOR BE-TA SUB-UNIT  P75
500A2'CL, MUR-INE CD3
J04'CL, RH D
4-6-2'CL, ESE  EX-TRA SHEEP E ANTI-GEN
163.14, P53
RF-IP16'CL, RHEUMA-TOID FAC-TOR
E26'CL, MELANOMA
RF49A, IGG MON-O-CLON-AL AU-TOAN-TI-BODY  RHEUMA-TOID FAC-TOR
36-7'CL, IN-FLUEN-ZA VIRUS  A PR 8 34  HEMAG-GLU-TININ
P11'CL, B2 GLY-CO-PRO-TEIN 1  KD = 1.6 X 10-EXP 6   PRO-THROM-BIN  KD = 3.2 X 10-EXP 6
CLONE 1D2'CL, HU-MAN RED BLOOD CELL
1F4'CL, ID-IOTOPE OF 4 4 20
F12, MESOTHE-LIN
D98, MOUSE KAP-PA LIGHT CHAIN  P AZOPHENY-LAR-SON-ATE BSA  ARS BSA   ID-IO-TYPE
L32'CL, THE AU-THORS ES-TI-MAT-ED THAT THERE ARE ABOUT 0.2 0.5% OF PE-RIPH-ER-AL BLOOD B LYM-PHO-CYTES WHICH ARE KAP-PA + AND LAMB-DA +.
417.F1.1.35'CL, MONORE-AC-TIVE
H146-24B3'CL, IN-FLUEN-ZA VIRUS HEMAG-GLU-TININ HY-BRIDO-MA
cDNA1-Hul'CL, IGG  RHEUMA-TOID FAC-TOR
T10-1'CL, T3 EPI-TOPE  GLY 225  OF IN-FLUEN-ZA VIRUS HEMAG-GLU-TININ
MA-15C5'CL, HU-MAN FIB-RIN FRAG-MENT D DIMER
N92'CL, HU-MAN N BLOOD GROUP ANTI-GEN
D9D10'CL, HU-MAN IN-TER-FER-ON GAM-MA
KO3-34'CL, ID-IO-TYPE OF HLA DQ3 AN-TI-BODY
DAUDI, ACHR
3381, TYPE III PNEU-MO-COC-CAL POLY-SAC-CHA-RIDE
16.3'CL, B1335 DEX
OKT3 scFv'CL, HU-MAN CD3 EP-SILON
D7.4'CL, AU-TOAN-TI ID-IO-TYP-IC MAB TO DNA MAB A52 IG-G2B KAP-PA
4422, TYPE II PNEU-MO-COC-CAL POLY-SAC-CHA-RIDE
hsiglvl962'CL, RAB-BIT IGG
HuNMVH'CL, HU-MAN HIGH BIND-ING AFFIN-I-TY RE-CEP-TOR FOR FC OF IGG  FC-GRI
PIE, AU-TOAN-TI-BODY WHICH BINDS SPECIF-I-CAL-LY TO IN-TER-ME-DI-ATE FIL-A-MENTS
DR12910-2F8'CL, DR 1 2 9 10 HY-BRIDO-MA
T1-107'CL, T3 EPI-TOPE  GLY 225  OF IN-FLUEN-ZA VIRUS HEMAG-GLU-TININ
WG4'CL, PRO-TEINASE 3
Q01'CL, RH D
cAbAMD10, AL-PHA AMY-LASE
CLONE 42PF'CL, LEUC-INE ZIP-PER
CLONE 1E3'CL, HU-MAN RED BLOOD CELL
KS13'CL, HLA DQ3
3-4'CL, IG-G2A
E26, MOUSE KAP-PA LIGHT CHAIN  P AZOPHENY-LAR-SON-ATE BSA  ARS BSA   ID-IO-TYPE
GN901v1.0, CD56
A28K'CL, IG-G2A
T4-57'CL, T3 EPI-TOPE  GLY 225  OF IN-FLUEN-ZA VIRUS HEMAG-GLU-TININ
3-7'CL, SM HY-BRIDO-MA
CL-G'CL, ERY-THRO-CYTE
BEN-27'CL, HI-S-T-ONE H1  RESIDUES 204 218
71.7, MYELIN OLIGO-DEN-DRO-CYTE GLY-CO-PRO-TEIN  MOG
262.9'CL, B1335 DEX
mAb65'CL, POLYRE-AC-TIVE IGG FC FRAG-MENT RHEUMA-TOID FAC-TOR
SCA, CRYO-GLOB-U-LIN WITH LOW DEN-SI-TY LIPOPRO-TEIN AC-TIV-I-TY; B ID-IO-TYPE
RF6-6K'CL, IG-G1
T5-131'CL, T3 EPI-TOPE  GLY 225  OF IN-FLUEN-ZA VIRUS HEMAG-GLU-TININ
B-33'CL, CATION IN-DE-PEN-DENT MAN-NOSE 6 PHOS-PHATE RE-CEP-TOR IN-SULIN LIKE GROWTH FAC-TOR TYPE  2 RE-CEP-TOR
163.15, P53
Y2'CL, SMALL NU-CLE-O-PRO-TEIN SM
A06, LYSOZYME HY-BRIDO-MA
3322-B, TYPE VI-II PNEU-MO-COC-CAL POLY-SAC-CHA-RIDE
131TP6H'CL, THY-ROID PER-OX-I-DASE  TPO
2F7'CL, HU-MAN PRO-COL-LA-GE-NASE
TA2'CL, TG
PE15'CL, HU-MAN PROENKEPHALIN  A NEU-ROPEP-TIDE PRE-CUR-SOR  PEP-TIDE 155DL-LKEL-L161
28E4'CL, RH D
cDNA6-Hul'CL, IGG  RHEUMA-TOID FAC-TOR
SM2R2A'CL, SM
3E5'CL, CRYP-TO-COC-CUS NE-O-FOR-MANS  SEROP-TYPE A  GLU-CURONOXY-LO-MAN-NAN TETANUS TOX-OID CON-JU-GATE
FS-7'CL, COLD AG-GLU-TININ
H10''CL, LAMININ
RF-2'CL, IG-G3 RHEUMA-TOID FAC-TOR
18B7'CL, CRYP-TO-COC-CUS NE-O-FOR-MANS  SEROP-TYPE A  GLU-CURONOXY-LO-MAN-NAN TETANUS TOX-OID CON-JU-GATE
126HH'CL, THY-ROID PER-OX-I-DASE  TPO
126'CL, HET-ERO-HY-BRIDO-MA AN-TI-BODY TO LYM-PHOMA CELLS POS-SESS-ING ID-IOTOPE RE-ACT-ING WITH ID-IO-TYPE 7D11 AF-TER TREAT-MENT WITH 7D11.
L26'CL, AU-TOAN-TI-BODY
D8'CL, THY-ROID PER-OX-I-DASE AU-TOAN-TI-BODY
hsiglvl150'CL, RAB-BIT IGG
L04'CL, RH D
21H9'CL, RH D
91.7, MYELIN OLIGO-DEN-DRO-CYTE GLY-CO-PRO-TEIN  MOG
alpha-poxn5, POXN
LS7'CL, PR2 RBC AU-TOAN-TI-BODY
F5-963'CL, ID-IO-TYP-IC AN-TI-BODY AGAINST HLA DR1 4 W14 W8 9 MAB AC1.59 COU-PLED WITH KEY-HOLE LIMPET HEMO-CYANIN
CB 20'CL, HU-MAN AND MOUSE TYPE II COL-LA-GEN C1 EPI-TOPE  RESIDUES 316 TO 333
HV1L1'CL, RHEUMA-TOID FAC-TOR
cAbCA06, CAR-BON-IC AN-HY-DRASE
HA-2'CL, IGG  NO ERY-THRO-CYTE AC-TIV-I-TY
2-2C8'CL, BROME-LAIN TREAT-ED MOUSE RBC HY-BRIDO-MA
Tg10'CL, HU-MAN THY-ROGLOB-U-LIN
mAb 126'CL, IN-SULIN HY-BRIDO-MA
IgG+ CLL'CL, B TYPE CHRON-IC LYM-PHO-CYT-IC LEUKEMIA  B CLL
131TP7H'CL, THY-ROID PER-OX-I-DASE  TPO
S01'CL, RH D
2G7'CL, SM HY-BRIDO-MA
HY18'CL, B CELL AU-TOAN-TI-BODY
GP-4'CL, ERY-THRO-CYTE
B9'CL, HU-MAN IN-TER-FER-ON GAM-MA RE-CEP-TOR
SP1.2'CL, THY-ROID PER-OX-I-DASE AU-TOAN-TI-BODY
ASWA1'CL, NU-CLE-O-LAR PAR-TI-CLES U3  U8 AND FIB-RIL-LAR-IN
AZ-42'CL, CAT-ALYT-IC AN-TI-BODY
69.7, MYELIN OLIGO-DEN-DRO-CYTE GLY-CO-PRO-TEIN  MOG
TB-1-M2'CL, RHEUMA-TOID FAC-TOR
POR'CL, FC IGG
2G4'CL, THY-ROID PER-OX-I-DASE AU-TOAN-TI-BODY
B72.3'CL, TU-MOR AS-SO-CI-AT-ED GLY-CO-PRO-TEIN 72  TAG 72
RF-TT5'CL, RHEUMA-TOID FAC-TOR
H17-L7'CL, CA CB SITE OF IN-FLUEN-ZA VIRUS A PR 8 34 HEMAG-GLU-TININ  PR8 HA
LS2'CL, PR2 RBC AU-TOAN-TI-BODY
20.119.25'CL, BALB C ID-IO-TYP-IC MON-O-CLON-AL AN-TI-BODY HP ID20 HY-BRIDO-MA
2-2G4'CL, BROME-LAIN TREAT-ED MOUSE RBC HY-BRIDO-MA
H120-2'CL, A PR 8 34 IN-FLUEN-ZA VIRUS HEMAG-GLU-TININ DI-RECT-ED TO THE CB SITE
T1'CL, HEN BOV-INE THY-ROGLOB-U-LIN
6F'CL, THY-ROID PER-OX-I-DASE AU-TOAN-TI-BODY
163.2, P53
N901H/G36005, CD56
FOG1-A3'CL, HU-MAN MAB FOG 1  IG-G1 KAP-PA
M5'CL, B TYPE CHRON-IC LYM-PHO-CYT-IC LEUKEMIA  B CLL
F4-3'CL, CON A
H11'CL, CAT-ALYT-IC AN-TI-BODY WHICH CATAL-Y-SES A DIELS ALDER CY-CLOAD-DI-TION RE-AC-TION
HP27'CL, PUB-LIC ID-IOTOPE HY-BRIDO-MA OF THE GAT SYS-TEM
MRA11K'CL, HI-S-T-ONE
Fab clone 1, RYE GRASS POLLEN AL-LER-GEN  KD = 2.63 X 10-EXP 9 M
B/SB5-28'CL, H2A H2B
F1_1252'CL, FRAC-TION 1
ABO.HI1'CL, HI
4F7'CL, EAR-LY NU-CLE-O-SOME AU-TOAN-TI-BODY  KD = 4X10-EXP 8
HIC5-4D1'CL, IN-FLUEN-ZA VIRUS HEMAG-GLU-TININ HY-BRIDO-MA
B72.3-1-3'CL, TAG72
A2, MESOTHE-LIN
RF3-2CR2K'CL, IG-G2A
MN12H2'CL, OUT-ER MEM-BRANE PRO-TEIN PO-RA OF NEIS-SE-RIA MENIN-GI-TIDIS
H37-80'CL, IN-FLUEN-ZA VIRUS HEMAG-GLU-TININ HY-BRIDO-MA
VH G61'CL, GLU-TATHI-ONE S TRANS-FERASE
TR1.9'CL, THY-ROID PER-OX-I-DASE AU-TOAN-TI-BODY
MD11'CL, TETANUS TOX-OID
E3G6'CL, GLY-CO-PRO-TEIN  GP  IA IIA
H152-42A3'CL, CA CB SITE OF IN-FLUEN-ZA VIRUS A PR 8 34 HEMAG-GLU-TININ  PR8 HA
2B12B3'CL, DER P 2   HOUSE DUST MITE AL-LER-GEN
126TP14H'CL, THY-ROID PER-OX-I-DASE  TPO
2E8'CL, BO-TULINUM NEU-RO-TOX-IN TYPE A BIND-ING DO-MAIN  BONT A HC
163.7, P53
46E7'CL, RH D
CB0010, RE-COM-BI-NANT HU-MAN TU-MOUR NECRO-SIS FAC-TOR AL-PHA
409'CL, P601E
CLONE 1E8'CL, HU-MAN RED BLOOD CELL
131TP8H'CL, THY-ROID PER-OX-I-DASE  TPO
CG-1'CL, ERY-THRO-CYTE
HUMLA1114'CL, KIM11.4
VL G69'CL, GLU-TATHI-ONE S TRANS-FERASE
AD14'CL, ERY-THRO-CYTE RH D
Ery.X1'CL, PANAG-GLU-TININ
126TP1K'CL, THY-ROID PER-OX-I-DASE  TPO
131'CL, AN-GIOTEN-SION II; ID-IO-TYP-IC AN-TI-BODY AGAINST MON-O-CLON-AL AN-TI-BODY 110
10-2'CL, IG-G2A
80.7, MYELIN OLIGO-DEN-DRO-CYTE GLY-CO-PRO-TEIN  MOG
F3, MESOTHE-LIN
RF-MR24'CL, RHEUMA-TOID FAC-TOR
ATM-1, TCR VBE-TA
M182'CL, B TYPE CHRON-IC LYM-PHO-CYT-IC LEUKEMIA  B CLL
89.7, MYELIN OLIGO-DEN-DRO-CYTE GLY-CO-PRO-TEIN  MOG
HPC4, HU-MAN PRO-TEIN C
3C8L'CL, MUR-INE SERUM AL-BU-MIN
VH6-19'CL, IG-G2A RHEUMA-TOID FAC-TOR
LV1L1'CL, RHEUMA-TOID FAC-TOR
38C13'CL, ID-IO-TYP-IC AN-TI-BODY HY-BRIDO-MA
163.17, P53
X3'CL, HU-MAN IN-TER-LEUKIN 1 AL-PHA
36-4'CL, IN-FLUEN-ZA VIRUS  A PR 8 34  HEMAG-GLU-TININ
SS629, P1.7 PO-RA PRO-TEIN LOOP OF NEIS-SE-RIA MENIN-GI-TIDIS
LN2 121'CL, MOUSE TYPE II COL-LA-GEN
93-6'CL, BE-TA SUB-UNIT OF ES-CHERICHIA COLI TRYP-TO-PHAN SYN-THETASE  BIND-ING CON-STAN-T=6.7X-EX-P9
L39'CL, AU-TOAN-TI-BODY
I07'CL, RH D
EL-16'CL, FAC-TOR VI-II
FS-4'CL, COLD AG-GLU-TININ
2-2'CL, IG-G2A
WRI-170'CL, HI-S-T-ONE H1  RESIDUES 1 16 AND 204 218
VL ii.'CL, GLU-TATHI-ONE S TRANS-FERASE
FV-ALPHA, HCG
L34'CL, AU-TOAN-TI-BODY
I02'CL, RH D
Ab44'CL, POLYRE-AC-TIVE AU-TOAN-TI-BODY
RF2-2'CL, IG-G2A
HA-RI'CL, ERY-THRO-CYTE
A9A7'CL, ACTIN  MYOSIN  TUBU-LIN  DS-D-NA  SS-D-NA AU-TOAN-TI-BODY  BIND-ING CON-TANTS RANGE BE-TWEEN 10-EX-P6 TO 10-EX-P8
RF4-4'CL, IG-G2A
E47, MOUSE KAP-PA LIGHT CHAIN  P AZOPHENY-LAR-SON-ATE BSA  ARS BSA   ID-IO-TYPE
81D2'CL, AU-TOAN-TI-BODY TO THY-ROGLOB-U-LIN
AD5/16'CL, ERY-THRO-CYTE RH D
RF5-5'CL, IG-G2A
Z36VH4'CL, CD20
Z85VH3'CL, CD20
slkv3'CL, IGG POLY-CLON-AL RHEUMA-TOID FAC-TOR
KC4G3'CL, HU-MAN BREAST MUCIN  AFFIN-I-TY CON-STAN-T=1.1X10-EX-P9
H3, MESOTHE-LIN
CL-D'CL, ERY-THRO-CYTE
1H4'CL, CD20
416.F2.2.34'CL, POLYRE-AC-TIVE
RF2-7'CL, IG-G2A
TNF-E7'CL, HU-MAN TU-MOR NECRO-SIS FAC-TOR AL-PHA
B14'CL, B2 GLY-CO-PRO-TEIN 1  KD = 7.0 X 10-EXP 5
1A6'CL, NU-CLE-O-SOME  TO-TAL HI-S-T-ONE  H2A H2B DIMER
C8'CL, HU-MAN IN-TER-FER-ON GAM-MA RE-CEP-TOR
2B9H'CL, MUR-INE SERUM AL-BU-MIN
NEW-based resh. CAMPATH-9, HU-MAN CD4
126TP2K'CL, THY-ROID PER-OX-I-DASE  TPO
GP-1'CL, ERY-THRO-CYTE
E42, MOUSE KAP-PA LIGHT CHAIN  P AZOPHENY-LAR-SON-ATE BSA  ARS BSA   ID-IO-TYPE
HuVH'CL, AL-PHA TOX-IN OF CLOSTRID-I-UM PER-FRIN-GENS  LOW AFFIN-I-TY
hsighvm148'CL, BE-TA AMY-LOID
RF-IP15'CL, RHEUMA-TOID FAC-TOR
RF-SJ5'CL, HU-MAN RAB-BIT IGG RHEUMA-TOID FAC-TOR
L2-10CL'CL, A PR 8 34 IN-FLUEN-ZA VIRUS HEMAG-GLU-TININ DI-RECT-ED TO THE CB SITE
1C6'CL, BO-TULINUM NEU-RO-TOX-IN TYPE A BIND-ING DO-MAIN  BONT A HC  EPI-TOPE 3  KD = 2.0 X 10-EXP 8
RF1-6'CL, IG-G2A
HUC'CL, SM
mAb426.4.2F20'CL, POLYRE-AC-TIVE AU-TOAN-TI-BODY
HA-8'CL, ERY-THRO-CYTE
7'CL, IN-SULIN
HuKLVH'CL, HU-MAN HIGH BIND-ING AFFIN-I-TY RE-CEP-TOR FOR FC OF IGG  FC-GRI
ASWU1'CL, NU-CLE-O-LAR PAR-TI-CLES U3  U8
1-10'CL, SM HY-BRIDO-MA
E6'CL, HU-MAN TRANS-FER-RIN RE-CEP-TOR
H37-82'CL, IN-FLUEN-ZA VIRUS HEMAG-GLU-TININ HY-BRIDO-MA
207,B-4, P1.7 PO-RA PRO-TEIN LOOP OF NEIS-SE-RIA MENIN-GI-TIDIS
Z31VH4'CL, CD20
VL iii.'CL, GLU-TATHI-ONE S TRANS-FERASE
4G11'CL, ID-IO-TYP-IC AN-TI-BODY AGAINST THE THY-ROTROPIN  TSH  RE-CEP-TOR
D05'CL, RH D
39D10, HU-MAN IL 5
3F10'CL, HU-MAN PRO-COL-LA-GE-NASE
DP-50'CL, ERY-THRO-CYTE RH D  AL-LOANTI-GEN
B-24'CL, CATION IN-DE-PEN-DENT MAN-NOSE 6 PHOS-PHATE RE-CEP-TOR IN-SULIN LIKE GROWTH FAC-TOR TYPE  2 RE-CEP-TOR
7-13'CL, SM HY-BRIDO-MA
lambda2'CL, HU-MAN THY-ROGLOB-U-LIN
BBLC434.22'CL, BAC-TE-RI-AL LEV-AN
HG2B10K'CL, GAN-GLIO-SIDE AU-TOAN-TI-BODY  GA1
SO4'CL, AN-TI9 HLA DQ3
126GK'CL, THY-ROID PER-OX-I-DASE  TPO
1G1.E9'CL, HORSE 44 47 CY-TOCHROME C
RFT2'CL, CD7
K02'CL, RH D
Z26'CL, SMITH ANTI-GEN HY-BRIDO-MA
TB-2-H68'CL, RHEUMA-TOID FAC-TOR
AZ-12'CL, CAT-ALYT-IC AN-TI-BODY
L3 11D'CL, EPI-DER-MAL GROWTH FAC-TOR RE-CEP-TOR
H2'CL, HU-MAN LIV-ER CELLS
3H4'CL, BO-TULINUM NEU-RO-TOX-IN TYPE A BIND-ING DO-MAIN  BONT A HC
H230-7'CL, IN-FLUEN-ZA VIRUS  A PR 8 34  HEMAG-GLU-TININ SEC-ONDARY AN-TI-BOD-IES  SB  HY-BRIDO-MA
E2''CL, HU-MAN PARATHY-ROID HOR-M-ONE RE-LAT-ED PRO-TEIN RESIDUES 1 TO 34  KA=6.8X10-EX-P8
2INH3'CL, HU-MAN IN-SULIN
ALN/17/172'CL, CHON-DROITIN SUL-PHATE PRO-TEO-GLY-CAN NG2  A TU-MOR SPE-CIF-IC ANTI-GEN ON THE 3 4 BEN-ZPYRENE IN-DUCED RAT CHON-DROSAR-CO-MA HSN
110'CL, KEY HOLE LIMPET HEMO-CYANIN COU-PLED AN-GIOTENSIN II
C9'CL, BO-TULINUM NEU-RO-TOX-IN TYPE A BIND-ING DO-MAIN  BONT A HC
HuVHNA'CL, AL-PHA TOX-IN OF CLOSTRID-I-UM PER-FRIN-GENS  MEDI-UM AFFIN-I-TY
16.7, MYELIN OLIGO-DEN-DRO-CYTE GLY-CO-PRO-TEIN  MOG
9F11'CL, CRYP-TO-COC-CUS NE-O-FOR-MANS  SEROP-TYPE A  GLU-CURONOXY-LO-MAN-NAN TETANUS TOX-OID CON-JU-GATE
KOL, CD56
YFC51.1'CL, HU-MAN CD18
126TP15K'CL, THY-ROID PER-OX-I-DASE  TPO
HYHEL-5, HEN EGG WHITE LYSOZYME
M02'CL, RH D
I10'CL, RH D
cAbCA05, CAR-BON-IC AN-HY-DRASE
2INH8'CL, HU-MAN IN-SULIN
B7'CL, HU-MAN CAR-DIAC MYOSIN
D18'CL, RH D
A7, MYELIN OLIGO-DEN-DRO-CYTE GLY-CO-PRO-TEIN  MOG
PR1(FV)-PE38KDEL'CL, PR1 ANTI-GEN ON HU-MAN PROSTATE CAN-CER CELLS AND NOR-MAL PROSTATE TIS-SUE
OVA'CL, CHICK-EN OVAL-BU-MIN
12ICI'CL, AU-TOAN-TI-BODY TO THY-ROGLOB-U-LIN
F(ab)-12, HU-MAN VAS-CU-LAR EN-DOTHE-LIAL GROWTH FAC-TOR  VEGF
A15'CL, IG-G1 MON-O-CLON-AL AU-TOAN-TI-BODY  RHEUMA-TOID FAC-TOR
17E12'CL, CRYP-TO-COC-CUS NE-O-FOR-MANS  SEROP-TYPE A  GLU-CURONOXY-LO-MAN-NAN TETANUS TOX-OID CON-JU-GATE
PR-TS1'CL, POLYRE-AC-TIVE RHEUMA-TOID FAC-TOR
D6'CL, THY-ROID PER-OX-I-DASE AU-TOAN-TI-BODY
GB4v2.0, CD19
RA-3-A3.2'CL, RHEUMA-TOID FAC-TOR
HUNVK'CL, MYELIN AS-SO-CI-AT-ED PRO-TEIN
6-2'CL, IG-G2A
DSC, ID-IO-TYP-IC
126TO15H'CL, THY-ROID PER-OX-I-DASE  TPO
AC21B'CL, HU-MAN CY-TOMEGALO-VIRUS  CMV  MEM-BRANE GLY-CO-PRO-TEIN GP58 116  GB  AD2 EPI-TOPE  RESIDUES 67 TO 86 OF GP116
E50, MOUSE KAP-PA LIGHT CHAIN  P AZOPHENY-LAR-SON-ATE BSA  ARS BSA   ID-IO-TYPE
VH G64'CL, GLU-TATHI-ONE S TRANS-FERASE
mAb 125'CL, IN-SULIN HY-BRIDO-MA
CH31'CL, E. COLI
a'CL, ID-IO-TYPE  EX-PRESSED ON THE SUR-FACE OF NON HODGKIN S LYM-PHOMA CELLS
E19, MOUSE KAP-PA LIGHT CHAIN  P AZOPHENY-LAR-SON-ATE BSA  ARS BSA   ID-IO-TYPE
25G09, LYSOZYME HY-BRIDO-MA
IE12'CL, F AB  2
mAb60'CL, MONORE-AC-TIVE IGG FC FRAG-MENT RHEUMA-TOID FAC-TOR
A4.6.1, VAS-CU-LAR EN-DOTHE-LIAL GROWTH FAC-TOR
CB 340'CL, HU-MAN AND MOUSE TYPE II COL-LA-GEN C1 EPI-TOPE  RESIDUES 316 TO 333
RF-TT9'CL, RHEUMA-TOID FAC-TOR
B'2 (Humkv328-Jk1)'CL, RHEUMA-TOID FAC-TOR
S12M1'CL, BROME-LAIN TREAT-ED MOUSE RBC  SHEEP RBC  TRIMETHY-LAM-MO-NI-UM HY-BRIDO-MA
D13'CL, RH D
67.7, MYELIN OLIGO-DEN-DRO-CYTE GLY-CO-PRO-TEIN  MOG
LG8-1'CL, NU-CLE-O-SOME
bkv17'CL, IGG POLY-CLON-AL RHEUMA-TOID FAC-TOR
A9'CL, IG-G1 MON-O-CLON-AL AU-TOAN-TI-BODY  RHEUMA-TOID FAC-TOR
B9601 (VH3-JH3)'CL, RHEUMA-TOID FAC-TOR
25G12'CL, CRYP-TO-COC-CUS NE-O-FOR-MANS  SEROP-TYPE A  GLU-CURONOXY-LO-MAN-NAN TETANUS TOX-OID CON-JU-GATE
2INL4'CL, HU-MAN IN-SULIN
MRA10H'CL, HI-S-T-ONE
14C10'CL, SM HY-BRIDO-MA
36-1'CL, IN-FLUEN-ZA VIRUS  A PR 8 34  HEMAG-GLU-TININ
bkv35'CL, IGG POLY-CLON-AL RHEUMA-TOID FAC-TOR
2INL9'CL, HU-MAN IN-SULIN
CLONE pMEK1HC'CL, HLA DR ANTI-GENS
Og-31'CL, ERY-THRO-CYTE RH D  AL-LOANTI-GEN
417.F22'CL, POLYRE-AC-TIVE
K1B12L'CL, GAN-GLIO-SIDE AU-TOAN-TI-BODY  GAL-GALNAC BSA  3 FL BSA
G28'CL, THE AU-THORS ES-TI-MAT-ED THAT THERE ARE ABOUT 0.2 0.5% OF PE-RIPH-ER-AL BLOOD B LYM-PHO-CYTES WHICH ARE KAP-PA + AND LAMB-DA +.
8-2'CL, IG-G2A
HuMc3, BA46  A 46 KDA GLY-CO-PRO-TEIN OF THE HU-MAN MILK FAT GLOB-ULE MEM-BRANE EX-PRESSED IN BREAST CAR-CI-NO-MA CELLS
H37-84'CL, IN-FLUEN-ZA VIRUS HEMAG-GLU-TININ HY-BRIDO-MA
1F6'CL, PI-GEON CY-TOCHROME C AND MOUSE CY-TOCHROME C
O02'CL, RH D
RF-3'CL, IG-G1 RHEUMA-TOID FAC-TOR
56R-3'CL, 3M 1
c'CL, ID-IO-TYPE  EX-PRESSED ON THE SUR-FACE OF NON HODGKIN S LYM-PHOMA CELLS
OX26'CL, RAT TRANS-FER-RIN RE-CEP-TOR
4H5'CL, MOUSE CY-TOCHROME C AROUND RESIDUE 62
R5A3K'CL, GAN-GLIO-SIDE AU-TOAN-TI-BODY  GA1
mAb111'CL, IGG FC FRAG-MENT RHEUMA-TOID FAC-TOR
RN90v1.1, CD56
Hb-5, FOETAL HAEMOGLOBIN  HBF
WAG'CL, RHEUMA-TOID FAC-TOR
L34'CL, HU-MAN CD4
hsiglvl1189'CL, RAB-BIT IGG
22G12'CL, SM HY-BRIDO-MA
126TP5K'CL, THY-ROID PER-OX-I-DASE  TPO
JV5'CL, IG-G1 MON-O-CLON-AL AU-TOAN-TI-BODY  RHEUMA-TOID FAC-TOR
126TP13H'CL, THY-ROID PER-OX-I-DASE  TPO
87.7, MYELIN OLIGO-DEN-DRO-CYTE GLY-CO-PRO-TEIN  MOG
126BH'CL, THY-ROID PER-OX-I-DASE  TPO
Di62'CL, HU-MAN TU-MOR NECRO-SIS FAC-TOR AL-PHA
RF-SB1'CL, RHEUMA-TOID FAC-TOR
B/SB5-35'CL, H4
A6'CL, HU-MAN IN-TER-FER-ON GAM-MA RE-CEP-TOR
5H11'CL, PI-GEON CY-TOCHROME C AND MOUSE CY-TOCHROME C
H250-6'CL, A PR 8 34 IN-FLUEN-ZA VIRUS HEMAG-GLU-TININ DI-RECT-ED TO THE CB SITE
1-8'CL, SM HY-BRIDO-MA
L4'CL, HEN EGG WHITE LYSOZYME
MabB23'CL, HU-MAN PLAS-MA APOLIPOPRO-TEIN B 100
7-13'CL, SM
Humkv305'CL, CROSS RE-AC-TIVE ID-IO-TYPES ON VK IGM AU-TO IGG
VH BEN'CL, LAMIN B AU-TOAN-TI-BODY
103-7E'CL, MOUSE RED BLOOD CELL AU-TOAN-TI-BOD-IES
RC6 (Vg-Jk5)'CL, RHEUMA-TOID FAC-TOR
M7-049'CL, ID-IO-TYP-IC AN-TI-BODY SPE-CIF-IC FOR CEA MAB MA208
C39'CL, BO-TULINUM NEU-RO-TOX-IN TYPE A BIND-ING DO-MAIN  BONT A HC  EPI-TOPE 2  KD = 2.3 X 10-EXP 9
11/160'CL, CHON-DROITIN SUL-PHATE PRO-TEO-GLY-CAN NG2  A TU-MOR SPE-CIF-IC ANTI-GEN ON THE 3 4 BEN-ZPYRENE IN-DUCED RAT CHON-DROSAR-CO-MA HSN
205.12'CL, ID-IOTOPE HY-BRIDO-MA
C08'CL, RH D
RC6 (VH4.22-JH4)'CL, RHEUMA-TOID FAC-TOR
F04, LYSOZYME HY-BRIDO-MA
mAb112'CL, IGG FC FRAG-MENT RHEUMA-TOID FAC-TOR
LES-C'CL, RHEUMA-TOID FAC-TOR
2A1'CL, SM HY-BRIDO-MA
1-10'CL, SM
A23'CL, IG-G1 MON-O-CLON-AL AU-TOAN-TI-BODY  RHEUMA-TOID FAC-TOR
HUL-mRF'CL, IGG  RHEUMA-TOID FAC-TOR
1C9'CL, MOUSE CY-TOCHROME C AROUND RESIDUE 62
RA-4-Pd18'CL, RHEUMA-TOID FAC-TOR
Gad-2'CL, ERY-THRO-CYTE RH D  AL-LOANTI-GEN
H09, LYSOZYME HY-BRIDO-MA
126DK'CL, THY-ROID PER-OX-I-DASE  TPO
Vk FUR1'CL, LAMIN B AU-TOAN-TI-BODY
AC11'CL, HU-MAN CY-TOMEGALO-VIRUS  CMV  MEM-BRANE GLY-CO-PRO-TEIN GP58 116  GB  AD2 EPI-TOPE  RESIDUES 67 TO 86 OF GP116
AC33'CL, HU-MAN CY-TOMEGALO-VIRUS  CMV  MEM-BRANE GLY-CO-PRO-TEIN GP58 116  GB  AD2 EPI-TOPE  RESIDUES 67 TO 86 OF GP116
4G9'CL, CRYP-TO-COC-CUS NE-O-FOR-MANS  SEROP-TYPE A  GLU-CURONOXY-LO-MAN-NAN TETANUS TOX-OID CON-JU-GATE
RF-DI1'CL, RHEUMA-TOID FAC-TOR
CC92'CL, TU-MOR AS-SO-CI-AT-ED GLY-CO-PRO-TEIN 72  TAG 72
GG48'CL, RHEUMA-TOID FAC-TOR
e'CL, ID-IO-TYPE  EX-PRESSED ON THE SUR-FACE OF NON HODGKIN S LYM-PHOMA CELLS
HP21'CL, PUB-LIC ID-IOTOPE HY-BRIDO-MA OF THE GAT SYS-TEM
R1-38'CL, ID-IO-TYPE OF HLA DQ3 AN-TI-BODY
C6'CL, HU-MAN IN-TER-FER-ON GAM-MA RE-CEP-TOR
KA3D1'CL, RHEUMA-TOID FAC-TOR
3C6'CL, FE-CAL BAC-TE-RIA
TB-3-D91'CL, RHEUMA-TOID FAC-TOR
HuVHCAMP'CL, HU-MAN LYM-PHO-CYTE HY-BRIDO-MA
L05'CL, RH D
RF-IP14'CL, RHEUMA-TOID FAC-TOR
H1, MESOTHE-LIN
A07, LYSOZYME HY-BRIDO-MA
cDNA5-Hul'CL, IGG  RHEUMA-TOID FAC-TOR
126TP6K'CL, THY-ROID PER-OX-I-DASE  TPO
LS8'CL, PR2 RBC AU-TOAN-TI-BODY
DA4.4/212'CL, HU-MAN IGM  KA = 3.03 X 10^9 M^ 1
2D9L'CL, MUR-INE SERUM AL-BU-MIN
B13H4C8'CL, MUR-INE ERY-THRO-CYTE AU-TOAN-TI-BODY
Rh.E1'CL, E
RF49'CL, IG-G1 MON-O-CLON-AL AU-TOAN-TI-BODY  RHEUMA-TOID FAC-TOR
21.3, MYELIN OLIGO-DEN-DRO-CYTE GLY-CO-PRO-TEIN  MOG
12F4'CL, CRYP-TO-COC-CUS NE-O-FOR-MANS  SEROP-TYPE A  GLU-CURONOXY-LO-MAN-NAN TETANUS TOX-OID CON-JU-GATE
GAN4B.5'CL, ERY-THRO-CYTE SUR-FACE ANTI-GEN  RHE-SUS D
9E10'CL, C MYC
638'CL, P601E
L202'CL, HU-MAN CD4
5-5'CL, IG-G2A
2F7'CL, FE-CAL BAC-TE-RIA
STRAb SA-1A'CL, ACTIN AL-PHA AC-TININ AU-TOAN-TI-BODY
WRD4'CL, RHEUMA-TOID FAC-TOR
mAb113'CL, IGG FC FRAG-MENT RHEUMA-TOID FAC-TOR
scFv(225.28S)'CL, HU-MAN HIGH MOLEC-U-LAR WEIGHT MELANOMA AS-SO-CI-AT-ED ANTI-GEN
19B8'CL, SM HY-BRIDO-MA
MRA3H'CL, HI-S-T-ONE
RFB4'CL, CD22
E03'CL, RH D
2-12'CL, SM HY-BRIDO-MA
61.1E9.9'CL, ID-IO-TYP-IC AN-TI-BODY
126TP7K'CL, THY-ROID PER-OX-I-DASE  TPO
B/SB5-62'CL, H2A H2B
1G7'CL, BO-TULINUM NEU-RO-TOX-IN TYPE A BIND-ING DO-MAIN  BONT A HC
Sulf-1'CL, P AZOPHENYL-SUL-FONATE KEY-HOLE LYM-PET HEMO-CYANIN
BSA3'CL, BOV-INE SERUM AL-BU-MIN
bkv6'CL, IGG POLY-CLON-AL RHEUMA-TOID FAC-TOR
A02, LYSOZYME HY-BRIDO-MA
1B3'CL, BO-TULINUM NEU-RO-TOX-IN TYPE A BIND-ING DO-MAIN  BONT A HC
BIII.136'CL, HU-MAN BAND 3 PRO-TEIN CY-TO-PLAS-MIC DO-MAIN
HUM1V1LI'CL, KIM11.4
M2 84'CL, MOUSE TYPE II COL-LA-GEN
3F4'CL, BO-TULINUM NEU-RO-TOX-IN TYPE A BIND-ING DO-MAIN  BONT A HC
g'CL, ID-IO-TYPE  EX-PRESSED ON THE SUR-FACE OF NON HODGKIN S LYM-PHOMA CELLS
72.3, MYELIN OLIGO-DEN-DRO-CYTE GLY-CO-PRO-TEIN  MOG
RF-DI2'CL, RHEUMA-TOID FAC-TOR
E49, MOUSE KAP-PA LIGHT CHAIN  P AZOPHENY-LAR-SON-ATE BSA  ARS BSA
F5-830'CL, ID-IO-TYP-IC AN-TI-BODY AGAINST HLA DR1 4 W14 W8 9 MAB AC1.59 COU-PLED WITH KEY-HOLE LIMPET HEMO-CYANIN
VS1'CL, IG-G1 MON-O-CLON-AL AU-TOAN-TI-BODY  RHEUMA-TOID FAC-TOR
S/SB5-41'CL, H4
MN14C11.6, P1.7 PO-RA PRO-TEIN LOOP OF NEIS-SE-RIA MENIN-GI-TIDIS
2BBLC803.1'CL, BAC-TE-RI-AL LEV-AN
126TP14K'CL, THY-ROID PER-OX-I-DASE  TPO
CLONE 1G7'CL, HU-MAN RED BLOOD CELL
G71'CL, MELANOMA
163.6, P53
B6.2'CL, HU-MAN CAR-CI-NO-MA CELL HY-BRIDO-MA WHICH RE-ACTS WITH HU-MAN BREAST  LUNG AND COLON CAR-CI-NO-MA
MRA5K'CL, HI-S-T-ONE
RF-IP24'CL, RHEUMA-TOID FAC-TOR
L22'CL, AU-TOAN-TI-BODY
T5-58'CL, T3 EPI-TOPE  GLY 225  OF IN-FLUEN-ZA VIRUS HEMAG-GLU-TININ
cAbCA04, CAR-BON-IC AN-HY-DRASE
TR1.3'CL, THY-ROID PER-OX-I-DASE AU-TOAN-TI-BODY
Y13-238 scFv'CL, P21 RAS
TB-2-H71'CL, RHEUMA-TOID FAC-TOR
H163-130H9'CL, A PR 8 34 IN-FLUEN-ZA VIRUS HEMAG-GLU-TININ DI-RECT-ED TO THE CB SITE
26-1'CL, ESE  EX-TRA SHEEP E ANTI-GEN
163.1, P53
B5'CL, HU-MAN IN-TER-FER-ON GAM-MA RE-CEP-TOR
TR1.8'CL, THY-ROID PER-OX-I-DASE AU-TOAN-TI-BODY
RSP1'CL, SM ANTI-GEN
PE19'CL, HU-MAN PROENKEPHALIN  A NEU-ROPEP-TIDE PRE-CUR-SOR  PEP-TIDE 155DL-LKEL-L161
53R-1'CL, 3M 1
lambda1'CL, HU-MAN THY-ROGLOB-U-LIN
MRA10K'CL, HI-S-T-ONE
Hb-2, FOETAL HAEMOGLOBIN  HBF
Bip 1'CL, BET V 1  MA-JOR BIRCH POLLEN AL-LER-GEN
MAb 4C1'CL, MAB 1 1
5.M13'CL, AU-TOAN-TI-BODY TO THE ACETYL-CHOLINE RE-CEP-TOR.
5C9'CL, MOUSE CY-TOCHROME C AROUND RESIDUE 62
417.32.F24.7'CL, MONORE-AC-TIVE
ABO.B1'CL, B
COU-1'CL, MOD-I-FIED CY-TOK-ER-ATIN
Sulf-2'CL, P AZOPHENYL-SUL-FONATE KEY-HOLE LYM-PET HEMO-CYANIN
B1-4'CL, HEN BOV-INE SERUM AL-BU-MIN
Bet 2/212'CL, MOUSE IGM  KA = 5 X 10^7 M^ 1
LN2 423'CL, MOUSE TYPE II COL-LA-GEN
Reg-A'CL, ERY-THRO-CYTE RH D  AL-LOANTI-GEN
RF-3 PAN'CL, IGG PAN RHEUMA-TOID FAC-TOR
F1_1259'CL, FRAC-TION 1
Z45VH1'CL, CD20
RF-KL5'CL, HU-MAN RAB-BIT IGG RHEUMA-TOID FAC-TOR
RF9-3'CL, IG-G2A
B13'CL, IG-G1 MON-O-CLON-AL AU-TOAN-TI-BODY  RHEUMA-TOID FAC-TOR
5F8.B7'CL, HORSE 60 CY-TOCHROME C
2-115-58'CL, ID-IO-TYP-IC AN-TI-BODY SPE-CIF-IC FOR MUR-INE MON-O-CLON-AL ACHR AN-TI-BODY 63
A8C8'CL, TETANUS TOX-OID
E07, LYSOZYME HY-BRIDO-MA
62H3'CL, HLA DR RHEUMA-TOID FAC-TOR AU-TOAN-TI-BODY
126TP8K'CL, THY-ROID PER-OX-I-DASE  TPO
F5-1126'CL, ID-IO-TYP-IC AN-TI-BODY AGAINST HLA DR1 4 W14 W8 9 MAB AC1.59 COU-PLED WITH KEY-HOLE LIMPET HEMO-CYANIN
RN901v1.1, CD56
T2-150'CL, T3 EPI-TOPE  GLY 225  OF IN-FLUEN-ZA VIRUS HEMAG-GLU-TININ
CLONE pMEK1LC'CL, HLA DR ANTI-GENS
E10'CL, MOUSE TYPE II COL-LA-GEN
RF7-1'CL, IG-G2A
126TO1K'CL, THY-ROID PER-OX-I-DASE  TPO
I08'CL, RH D
TT117'CL, TETANUS TOX-IN  TOX-OID AND A FRAG-MENT  LIGHT CHAIN  OF TETANUS TOX-IN
RF8-2'CL, IG-G2A
AD6'CL, ERY-THRO-CYTE RH D
S5P14'CL, RHEUMA-TOID FAC-TOR
9-5'CL, IG-G2A
GLO, HU-MAN GAM-MA G GLOB-U-LIN; WA ID-IO-TYPE; CRYO-GLOB-U-LIN WITH IGG AC-TIV-I-TY; B ID-IO-TYPE
T6-19'CL, T3 EPI-TOPE  GLY 225  OF IN-FLUEN-ZA VIRUS HEMAG-GLU-TININ
RF-TS1'CL, RHEUMA-TOID FAC-TOR AU-TOAN-TI-BODY
D61, MOUSE KAP-PA LIGHT CHAIN  P AZOPHENY-LAR-SON-ATE BSA  ARS BSA   ID-IO-TYPE
Z32VH3'CL, CD20
HEW''CL, AU-TOAN-TI-BODY
MICA 1'CL, GLU-TA-MATE DE-CAR-BOXY-LASE  MA-JOR ISLET CELL AU-TOANTI-GEN
EL-9'CL, FAC-TOR VI-II
QB1'CL, CHRO-MATIN
81C6'CL, TENASCIN
mAb410.7.F91'CL, POLYRE-AC-TIVE AU-TOAN-TI-BODY
1F3'CL, BO-TULINUM NEU-RO-TOX-IN TYPE A BIND-ING DO-MAIN  BONT A HC  EPI-TOPE 4  KD = 1.2 X 10-EXP 8
m32Y/S, ID-IO-TYP-IC
F12'CL, DESMO-SOME AU-TOAN-TI-BODY
2E10'CL, SM HY-BRIDO-MA
12D11'CL, SM HY-BRIDO-MA
CLONE 1C8'CL, HU-MAN RED BLOOD CELL
E5'CL, MOUSE TYPE II COL-LA-GEN
18F7'CL, SM HY-BRIDO-MA
ITC88'CL, HU-MAN CY-TOMEGALO-VIRUS  CMV  MEM-BRANE GLY-CO-PRO-TEIN GP58 116  GB  AD2 EPI-TOPE  RESIDUES 67 TO 86 OF GP116
B01'CL, RH D
REGA-3G12'CL, NEU-TROPHIL GELATI-NASE B
GOT, CRYO-GLOB-U-LIN WITH IGG AC-TIV-I-TY; B ID-IO-TYPE
M2 332'CL, MOUSE TYPE II COL-LA-GEN
A09'CL, HU-MAN M BLOOD GROUP ANTI-GEN
KO3-256'CL, ID-IO-TYPE OF HLA DQ3 AN-TI-BODY
85.7, MYELIN OLIGO-DEN-DRO-CYTE GLY-CO-PRO-TEIN  MOG
BMA 031-EUCIV2'CL, HU-MAN T CELL RE-CEP-TOR HU-MAN-IZED AN-TI-BODY
C3'CL, THY-ROID PER-OX-I-DASE AU-TOAN-TI-BODY
Mad-2'CL, ERY-THRO-CYTE RH D  AL-LOANTI-GEN
L30'CL, AU-TOAN-TI-BODY
22.202.16'CL, BALB C ID-IO-TYP-IC MON-O-CLON-AL AN-TI-BODY HP ID22 HY-BRIDO-MA
126TP9K'CL, THY-ROID PER-OX-I-DASE  TPO
CB 239'CL, HU-MAN AND MOUSE TYPE II COL-LA-GEN C1 EPI-TOPE  RESIDUES 316 TO 333
ASWB1'CL, NU-CLE-O-LAR PAR-TI-CLES U3  U8
Sulf-3'CL, P AZOPHENYL-SUL-FONATE KEY-HOLE LYM-PET HEMO-CYANIN
Fog-3'CL, ERY-THRO-CYTE RH D  AL-LOANTI-GEN
CEM231.6.7'CL, HU-MAN CAR-CI-NOEM-BRY-ON-IC ANTI-GEN HY-BRIDO-MA
VH G69'CL, GLU-TATHI-ONE S TRANS-FERASE
126TO2K'CL, THY-ROID PER-OX-I-DASE  TPO
RF-MR5'CL, RHEUMA-TOID FAC-TOR
NANUC-2'CL, NEU-TROPHIL
PE22'CL, HU-MAN PROENKEPHALIN  A NEU-ROPEP-TIDE PRE-CUR-SOR  PEP-TIDE 175GS-D-NEEEVSKR185
S/SB5-72'CL, H4
6H2.B4'CL, RAT 62 CY-TOCHROME C
F1_1357'CL, FRAC-TION 1
HuHMFG1'CL, HU-MAN MUCIN
WRD1'CL, RHEUMA-TOID FAC-TOR
C7, MESOTHE-LIN
4A9.D6'CL, HORSE 47 CY-TOCHROME C
slkv7'CL, IGG POLY-CLON-AL RHEUMA-TOID FAC-TOR
F1_1260'CL, FRAC-TION 1
MICA 2'CL, GLU-TA-MATE DE-CAR-BOXY-LASE  MA-JOR ISLET CELL AU-TOANTI-GEN
H36-12'CL, IN-FLUEN-ZA VIRUS  A PR 8 34  HEMAG-GLU-TININ SEC-ONDARY AN-TI-BOD-IES  SB  HY-BRIDO-MA
VH i.'CL, GLU-TATHI-ONE S TRANS-FERASE
Anti-B4, CD19
GF4/1.1'CL, TETANUS TOX-OID
Ab26'CL, POLYRE-AC-TIVE AU-TOAN-TI-BODY
Id-F2'CL, ID FH 6  WHICH IS AN AN-TI-BODY AGAINST SIA-LYL SSEA 1
DB3'CL, PRO-GES-TER-ONE HY-BRIDO-MA
C10, LYSOZYME HY-BRIDO-MA
H37-311'CL, IN-FLUEN-ZA VIRUS HEMAG-GLU-TININ HY-BRIDO-MA
kappa1'CL, HU-MAN THY-ROGLOB-U-LIN
Z86VH4'CL, CD20
K03'CL, RH D
S1P15'CL, RHEUMA-TOID FAC-TOR
12A1'CL, CRYP-TO-COC-CUS NE-O-FOR-MANS  SEROP-TYPE A  GLU-CURONOXY-LO-MAN-NAN TETANUS TOX-OID CON-JU-GATE
M7-625'CL, ID-IO-TYP-IC AN-TI-BODY SPE-CIF-IC FOR CEA MAB MA208
CC83'CL, TU-MOR AS-SO-CI-AT-ED GLY-CO-PRO-TEIN 72  TAG 72
417.F29'CL, MONORE-AC-TIVE
FS-8'CL, COLD AG-GLU-TININ
F5-1419'CL, ID-IO-TYP-IC AN-TI-BODY AGAINST HLA DR1 4 W14 W8 9 MAB AC1.59 COU-PLED WITH KEY-HOLE LIMPET HEMO-CYANIN
E4-12'CL, CON A
R1C8K'CL, GAN-GLIO-SIDE AU-TOAN-TI-BODY  GA1
clone 2'CL, F AB  2 AU-TOAN-TI-BODY
4C11'CL, TEPC15 ID-IO-TYPE AN-TI-BODY HY-BRIDO-MA
Sulf-4'CL, P AZOPHENYL-SUL-FONATE KEY-HOLE LYM-PET HEMO-CYANIN
hsiglvk643'CL, RAB-BIT IGG
RF-ET13'CL, RHEUMA-TOID FAC-TOR
MP1'CL, HLA CLASS II  DQB1*0201
VH ii.'CL, GLU-TATHI-ONE S TRANS-FERASE
PR1-3'CL, NU-CLE-O-SOME
1-42'CL, SM HY-BRIDO-MA
D01'CL, RH D
SM2K'CL, SM
AD10/13'CL, ERY-THRO-CYTE RH D
PA1'CL, CHRO-MATIN
2B9L'CL, MUR-INE SERUM AL-BU-MIN
IgG+ CL'CL, B TYPE CHRON-IC LYM-PHO-CYT-IC LEUKEMIA  B CLL
TW4.20'CL, HU-MAN TRANS-FER-RIN  KA = 1.70 X 10-EX-P9
MAL'CL, POLYRE-AC-TIVE
JU17'CL, ID-IO-TYP-IC AN-TI-BODY
BBLC310.2'CL, BAC-TE-RI-AL LEV-AN
28.3, MYELIN OLIGO-DEN-DRO-CYTE GLY-CO-PRO-TEIN  MOG
P61B27'CL, RE-HEUMA-TOID FAC-TOR
H130-5'CL, A PR 8 34 IN-FLUEN-ZA VIRUS HEMAG-GLU-TININ DI-RECT-ED TO THE CB SITE
I16'CL, RH D
H35-D1'CL, IN-FLUEN-ZA VIRUS  A PR 8 34  HEMAG-GLU-TININ SEC-ONDARY AN-TI-BOD-IES  SB  HY-BRIDO-MA
PE16'CL, HU-MAN PROENKEPHALIN  A NEU-ROPEP-TIDE PRE-CUR-SOR  PEP-TIDE 155DL-LKEL-L161
Ham-B'CL, ERY-THRO-CYTE RH D  AL-LOANTI-GEN
8G3'CL, SM HY-BRIDO-MA
B/SB5-39'CL, H2A H2B
T6-626'CL, T3 EPI-TOPE  GLY 225  OF IN-FLUEN-ZA VIRUS HEMAG-GLU-TININ
RF-IP13'CL, RHEUMA-TOID FAC-TOR
clone 28'CL, TIM-O-THY GRASS POLLEN MA-JOR AL-LER-GEN PHI P 5
CLONE 13AD'CL, LEUC-INE ZIP-PER
C15'CL, BO-TULINUM NEU-RO-TOX-IN TYPE A BIND-ING DO-MAIN  BONT A HC
3E5'CL, MOUSE CY-TOCHROME C AROUND RESIDUE 62
6A4'CL, PSEU-DOMONAS AERUG-I-NOSA OUT-ER MEM-BRANE PRO-TEIN I
RF2-11'CL, IG-G2A
2INH2'CL, HU-MAN IN-SULIN
Y12'CL, SM HY-BRIDO-MA
3B12-1'CL, HELA NU-CLE-AR EX-TRACT
M-T310'CL, HU-MAN CD4
T10-649'CL, HLA A2 28 MAB CR11 351 COU-PLED TO KEY-HOLE LIMPET HEMO-CYANIN
E4-17'CL, CON A
BrM11'CL, E. COLI  BROME-LAIN TREAT-ED MOUSE RBC HY-BRIDO-MA
kappa2'CL, HU-MAN THY-ROGLOB-U-LIN
3F6'CL, NU-CLE-O-SOME  TO-TAL HI-S-T-ONE  H2A H2B DIMER
2INH7'CL, HU-MAN IN-SULIN
74.7, MYELIN OLIGO-DEN-DRO-CYTE GLY-CO-PRO-TEIN  MOG
M03'CL, RH D
I11'CL, RH D
3707 E9'CL, SHIGEL-LA DYSEN-TE-RI-AE TYPE I
MICA 3'CL, GLU-TA-MATE DE-CAR-BOXY-LASE  MA-JOR ISLET CELL AU-TOANTI-GEN
2B6'CL, BO-TULINUM NEU-RO-TOX-IN TYPE A BIND-ING DO-MAIN  BONT A HC
BLI'CL, MYELIN AS-SO-CI-AT-ED GLY-CO-PRO-TEIN AND SUL-FAT-ED GLU-CURON-IC PARA-GLO-BO-SIDE
VH iii.'CL, GLU-TATHI-ONE S TRANS-FERASE
HSCFV198'CL, ACHR
DPD'CL, GLU-TAM-IC ACID DE-CAR-BOXY-LASE 65
LN2 189'CL, MOUSE TYPE II COL-LA-GEN
R6B8K'CL, GAN-GLIO-SIDE AU-TOAN-TI-BODY  GA1
AC18'CL, HU-MAN CY-TOMEGALO-VIRUS  CMV  MEM-BRANE GLY-CO-PRO-TEIN GP58 116  GB  AD2 EPI-TOPE  RESIDUES 67 TO 86 OF GP116
E29, MOUSE KAP-PA LIGHT CHAIN  P AZOPHENY-LAR-SON-ATE BSA  ARS BSA
126TO15K'CL, THY-ROID PER-OX-I-DASE  TPO
3A5-1'CL, METATOPE OF 4 4 20
mAb3G-10'CL, HU-MAN IL2 RE-CEP-TOR TAC PRO-TEIN
R18-9'CL, ID-IO-TYPE OF HLA DQ3 AN-TI-BODY
62'CL, THY-ROGLOB-U-LIN AU-TOAN-TI-BODY HY-BRIDO-MA
Brad-3'CL, ERY-THRO-CYTE RH D  AL-LOANTI-GEN
scFv-KJ16 wild-type'CL, T CELL RE-CEP-TOR  V BE-TA8 RE-GION
VH HER2'CL, LAMIN B AU-TOAN-TI-BODY
s6H12'CL, CAR-DI-OLIPIN AU-TOAN-TI-BODY
LB8'CL, PAS-TEUREL-LA PNEU-MOTROP-I-CA HY-BRIDO-MA
SA-4B'CL, TITIN AU-TOAN-TI-BODY
MF8 (VH4.22-JH4)'CL, RHEUMA-TOID FAC-TOR
RF3-5A'CL, IG-G1
SCFV198'CL, ACHR
B/SB5-3'CL, H4
Meso 4, MESOTHE-LIN POS-I-TIVE CELLS  BUT NOT RE-COM-BI-NANT MESOTHE-LIN
Sulf-5'CL, P AZOPHENYL-SUL-FONATE KEY-HOLE LYM-PET HEMO-CYANIN
GB4v1.0, CD19
7G7'CL, CRYP-TO-COC-CUS NE-O-FOR-MANS  SEROP-TYPE A  GLU-CURONOXY-LO-MAN-NAN TETANUS TOX-OID CON-JU-GATE
JSJ-1, POLYAM-INE  CROSS RE-ACTS WITH PU-TRESC-INE AND SPER-MINE
H151-31D10'CL, CA CB SITE OF IN-FLUEN-ZA VIRUS A PR 8 34 HEMAG-GLU-TININ  PR8 HA
AD21'CL, ERY-THRO-CYTE RH D
8.18-C5'CL, MYELIN OLIGO-DEN-DRO-CYTE GLY-CO-PRO-TEIN  MOG
H130-6'CL, A PR 8 34 IN-FLUEN-ZA VIRUS HEMAG-GLU-TININ DI-RECT-ED TO THE CB SITE
23'CL, IN-SULIN
F4'CL, MOUSE TYPE II COL-LA-GEN
Fab-7, HU-MAN PRO-TEIN C
F01'CL, RH D
AT13/5'CL, CD38  A SUR-FACE ANTI-GEN ON MYELO-MA CELLS
2D10'CL, CRYP-TO-COC-CUS NE-O-FOR-MANS  SEROP-TYPE A  GLU-CURONOXY-LO-MAN-NAN TETANUS TOX-OID CON-JU-GATE
A1'CL, AB3  SEE NOTES
2INL3'CL, HU-MAN IN-SULIN
MICA 4'CL, GLU-TA-MATE DE-CAR-BOXY-LASE  MA-JOR ISLET CELL AU-TOANTI-GEN
L71'CL, HU-MAN CD4
304'CL, IN-SULIN
CG-2'CL, ERY-THRO-CYTE
S5P3'CL, RHEUMA-TOID FAC-TOR
L2H7'CL, CAR-DI-OLIPIN AU-TOAN-TI-BODY
4A6'CL, METATOPE OF 4 4 20
2C8'CL, HU-MAN IN-TER-LEUKIN 2 RE-CEP-TOR AL-PHA SUB-UNIT  TAC PRO-TEIN
m95-99, ID-IO-TYP-IC
126TP13K'CL, THY-ROID PER-OX-I-DASE  TPO
CP3 23-24'CL, BROME-LAIN TREAT-ED MOUSE RED BLOOD CELL HY-BRIDO-MA
3T74, TYPE III PNEU-MO-COC-CAL POLY-SAC-CHA-RIDE
G10, LYSOZYME HY-BRIDO-MA
82B6'CL, AU-TOAN-TI-BODY TO THY-ROGLOB-U-LIN
kappa3'CL, HU-MAN THY-ROGLOB-U-LIN
D14'CL, RH D
bkv16'CL, IGG POLY-CLON-AL RHEUMA-TOID FAC-TOR
P13'CL, PRO-THROM-BIN  KD = 1.4 X 10-EXP 6
2C5-3'CL, 88 KDA SPLIC-ING FAC-TOR 53 4
234'CL, P601E
CC49'CL, TU-MOR AS-SO-CI-AT-ED GLY-CO-PRO-TEIN 72  TAG 72
CBL166.10.28'CL, BAC-TE-RI-AL LEV-AN
NM3E2 scFv, CD16
H01'CL, RH D
O03'CL, RH D
HuVHNIKNA'CL, AL-PHA TOX-IN OF CLOSTRID-I-UM PER-FRIN-GENS  HIGH AFFIN-I-TY
E73, MOUSE KAP-PA LIGHT CHAIN  P AZOPHENY-LAR-SON-ATE BSA  ARS BSA
mAb 123'CL, IN-SULIN HY-BRIDO-MA
3B10'CL, NU-CLE-O-SOME  TO-TAL HI-S-T-ONE  H2A H2B DIMER
N901H/PLO123, CD56
H152-42B11'CL, CA CB SITE OF IN-FLUEN-ZA VIRUS A PR 8 34 HEMAG-GLU-TININ  PR8 HA
CEA 66-E3'CL, CAR-CI-NOEM-BRY-ON-IC ANTI-GEN
G3D10K'CL, GAN-GLIO-SIDE AU-TOAN-TI-BODY  GM1  GA1  GAL-GALNAC BSA  NL-C4  3 FL BSA
2INH10'CL, HU-MAN IN-SULIN
1-6'CL, IG-G2A
7B6'CL, SM
E4-9'CL, CON A
TEL14'CL, TURKEY EGG WHITE LYSOZYME
2INL8'CL, HU-MAN IN-SULIN
Sulf-6'CL, P AZOPHENYL-SUL-FONATE KEY-HOLE LYM-PET HEMO-CYANIN
H2-4C2'CL, A PR 8 34 IN-FLUEN-ZA VIRUS HEMAG-GLU-TININ DI-RECT-ED TO THE CB SITE
3G8'CL, FE-CAL BAC-TE-RIA
2H1''CL, CRYP-TO-COC-CUS NE-O-FOR-MANS  SEROP-TYPE A  GLU-CURONOXY-LO-MAN-NAN TETANUS TOX-OID CON-JU-GATE
JV6'CL, IG-G1 MON-O-CLON-AL AU-TOAN-TI-BODY  RHEUMA-TOID FAC-TOR
A3, DI-HY-DROFLAVONOL 4 RE-DUC-TASE FROM PETU-NIA HY-BRI-DA
A5'CL, IG-G1 MON-O-CLON-AL AU-TOAN-TI-BODY  RHEUMA-TOID FAC-TOR
81B1'CL, AU-TOAN-TI-BODY TO THY-ROGLOB-U-LIN
5H4'CL, EAR-LY NU-CLE-O-SOME AU-TOAN-TI-BODY  KD = 9.8X10-EXP 8
H35-C7'CL, A PR 8 34 IN-FLUEN-ZA VIRUS HEMAG-GLU-TININ DI-RECT-ED TO THE CB SITE
28B4.2'CL, CAT-ALYT-IC AN-TI-BODY
9H12.2'CL, HI-S-T-ONE
LES-B'CL, RHEUMA-TOID FAC-TOR
LG2-2'CL, BOV-INE THY-MUS HI-S-T-ONES  H2B RES. 1 13
56R-7'CL, 3M 1
Z17VH3'CL, CD20
BLY3'CL, CD19
2097'CL, BAC-TE-RI-AL LEV-AN
115'CL, HET-ERO-HY-BRIDO-MA AN-TI-BODY TO LYM-PHOMA CELLS POS-SESS-ING ID-IOTOPE RE-ACT-ING WITH ID-IO-TYPE 7D11 AF-TER TREAT-MENT WITH 7D11.
kappa4'CL, HU-MAN THY-ROGLOB-U-LIN
22.111.1'CL, BALB C ID-IO-TYP-IC MON-O-CLON-AL AN-TI-BODY HP ID22 HY-BRIDO-MA
MICA 5'CL, GLU-TA-MATE DE-CAR-BOXY-LASE  MA-JOR ISLET CELL AU-TOANTI-GEN
COL'CL, POLYRE-AC-TIVE
H220-11'CL, CA CB SITE OF IN-FLUEN-ZA VIRUS A PR 8 34 HEMAG-GLU-TININ  PR8 HA
FS-5'CL, COLD AG-GLU-TININ
2INH11'CL, HU-MAN IN-SULIN
1A1'CL, BO-TULINUM NEU-RO-TOX-IN TYPE A BIND-ING DO-MAIN  BONT A HC
D3'CL, HU-MAN IN-TER-FER-ON GAM-MA RE-CEP-TOR
E37, MOUSE KAP-PA LIGHT CHAIN  P AZOPHENY-LAR-SON-ATE BSA  ARS BSA
J06'CL, RH D
R1C8H'CL, GAN-GLIO-SIDE AU-TOAN-TI-BODY  GAL-GALNAC BSA  3 FL BSA
mAb410.30F305'CL, POLYRE-AC-TIVE AU-TOAN-TI-BODY
H158-89H4'CL, IN-FLUEN-ZA VIRUS HEMAG-GLU-TININ HY-BRIDO-MA
V86'CL, MELANOMA
S8P10'CL, RHEUMA-TOID FAC-TOR
Dob1'CL, STREP-TO-COC-CUS PNEU-MO-NI-AE 6B
REI-based resh. CAMPATH-9, HU-MAN CD4
HP25'CL, PUB-LIC ID-IO-TYPE HY-BRIDO-MA OF THE GAT SYS-TEM
D1.3, LYSOZYME HY-BRIDO-MA
F6, MESOTHE-LIN
83.7, MYELIN OLIGO-DEN-DRO-CYTE GLY-CO-PRO-TEIN  MOG
F1_1485'CL, FRAC-TION 1
gammaR99'CL, HU-MAN IN-TER-FER-ON GAM-MA RE-CEP-TOR
CD4-74'CL, HU-MAN RE-COM-BI-NANT CD4
J01'CL, RH D
N901H, CD56
7A9, E SE-LECTIN  AN EN-DOTHE-LIAL LEUKO-CYTE AD-HE-SION MOLECULE 1
PE13'CL, HU-MAN PROENKEPHALIN  A NEU-ROPEP-TIDE PRE-CUR-SOR  PEP-TIDE 175GS-D-NEEEVSKR185
mAb63'CL, POLYRE-AC-TIVE IGG FC FRAG-MENT RHEUMA-TOID FAC-TOR
SCH94.03'CL, AU-TOAN-TI-BODY RE-AC-TIVE WITH SPEC-TRIN   4 HYR-DOXY 3 NI-TRO-PHENYL ACETYL  AND FLU-O-RES-CEIN  WHICH  PRO-MOTES CEN-TRAL NER-VOUS SYS-TEM RE-MYELI-NA-TION
126FH'CL, THY-ROID PER-OX-I-DASE  TPO
316'CL, P601E
126TP1H'CL, THY-ROID PER-OX-I-DASE  TPO
Sulf-7'CL, P AZOPHENYL-SUL-FONATE KEY-HOLE LYM-PET HEMO-CYANIN
C04'CL, RH D
Lym-1'CL, AN-TI-BODY USED IN CAN-CER THER-A-PY
C1'CL, THY-ROID PER-OX-I-DASE AU-TOAN-TI-BODY
RF-7'CL, IG-G1 RHEUMA-TOID FAC-TOR
NANUC-1'CL, NEU-TROPHIL
L7'CL, AU-TOAN-TI-BODY
cDNA4-Hul'CL, IGG  RHEUMA-TOID FAC-TOR
126TO6K'CL, THY-ROID PER-OX-I-DASE  TPO
S1P9'CL, RHEUMA-TOID FAC-TOR
F1_1171'CL, FRAC-TION 1
18.1'CL, BAC-TE-RI-AL LEV-AN
LN2 15'CL, MOUSE TYPE II COL-LA-GEN
kappa5'CL, HU-MAN THY-ROGLOB-U-LIN
Ab17'CL, POLYRE-AC-TIVE AU-TOAN-TI-BODY
F5-2'CL, ACTIN  MYOSIN  TUBU-LIN  DS-D-NA  SS-D-NA AU-TOAN-TI-BODY  BIND-ING CON-TANTS RANGE BE-TWEEN 10-EX-P6 TO 10-EX-P8
2INH12'CL, HU-MAN IN-SULIN
AC37'CL, HU-MAN CY-TOMEGALO-VIRUS  CMV  MEM-BRANE GLY-CO-PRO-TEIN GP58 116  GB  AD2 EPI-TOPE  RESIDUES 67 TO 86 OF GP116
AC15'CL, HU-MAN CY-TOMEGALO-VIRUS  CMV  MEM-BRANE GLY-CO-PRO-TEIN GP58 116  GB  AD2 EPI-TOPE  RESIDUES 67 TO 86 OF GP116
hu PR1A3, CELL BOUND CAR-CI-NOEM-BRY-ON-IC ANTI-GEN
FIF, I
MICA 6'CL, GLU-TA-MATE DE-CAR-BOXY-LASE  MA-JOR ISLET CELL AU-TOANTI-GEN
CP8 B3-D3'CL, BROMELIN-IZED MOUSE RED BLOOD CELL  BRM-R-BC  HY-BRIDO-MA
L47'CL, THE AU-THORS ES-TI-MAT-ED THAT THERE ARE ABOUT 0.2 0.5% OF PE-RIPH-ER-AL BLOOD B LYM-PHO-CYTES WHICH ARE KAP-PA + AND LAMB-DA +.
C11'CL, THY-ROID PER-OX-I-DASE AU-TOAN-TI-BODY
WG1'CL, PRO-TEINASE 3
87.92.6'CL, 9B.G5 AN-TI-BODY HY-BRIDO-MA
126HK'CL, THY-ROID PER-OX-I-DASE  TPO
FS-2'CL, ID-IO-TYP-IC 9G4
B/SB5-65'CL, H2A H2B
131TP15H'CL, THY-ROID PER-OX-I-DASE  TPO
'CL, MELANOMA
RF34, IGG MON-O-CLON-AL AU-TOAN-TI-BODY  RHEUMA-TOID FAC-TOR
124'CL, P601E
417.F28'CL, MONORE-AC-TIVE
Vl HER1'CL, LAMIN B AU-TOAN-TI-BODY
S4P11'CL, RHEUMA-TOID FAC-TOR
LES, RHEUMA-TOID FAC-TOR
CLONE 1B4'CL, HU-MAN RED BLOOD CELL
kappa6'CL, HU-MAN THY-ROGLOB-U-LIN
AH80-5, TYPE III PNEU-MO-COC-CAL POLY-SAC-CHA-RIDE
752'CL, P601E
37-63'CL, IN-FLUEN-ZA VIRUS  A PR 8 34  HEMAG-GLU-TININ
L01'CL, RH D
34-2B'CL, MOUSE RED BLOOD CELL AU-TOAN-TI-BOD-IES
H50'CL, LAMININ
LS4'CL, PR2 RBC AU-TOAN-TI-BODY
H61-15'CL, A PR 8 34 IN-FLUEN-ZA VIRUS HEMAG-GLU-TININ DI-RECT-ED TO THE CB SITE
ARM'CL, MYELIN AS-SO-CI-AT-ED GLY-CO-PRO-TEIN
RF-SJ4'CL, MONORE-AC-TIVE RHEUMA-TOID FAC-TOR
L2 12B'CL, EPI-DER-MAL GROWTH FAC-TOR RE-CEP-TOR
VS2'CL, IG-G1 MON-O-CLON-AL AU-TOAN-TI-BODY  RHEUMA-TOID FAC-TOR
RF-ET12'CL, RHEUMA-TOID FAC-TOR
RF-IP4'CL, RHEUMA-TOID FAC-TOR
82B6b'CL, AU-TOAN-TI-BODY TO THY-ROGLOB-U-LIN
MOPC-467, FLAG-ELLIN
7C5'CL, SM HY-BRIDO-MA
11A10'CL, SM HY-BRIDO-MA
W5.1B4.4'CL, ID-IO-TYP-IC AN-TI-BODY
Ab25'CL, THY-ROGLOB-U-LIN AU-TOAN-TI-BODY
CH10'CL, E. COLI
RF-IP12'CL, RHEUMA-TOID FAC-TOR
2D12'CL, LA PRO-TEIN  SS B
ALN/11/53'CL, CHON-DROITIN SUL-PHATE PRO-TEO-GLY-CAN NG2  A TU-MOR SPE-CIF-IC ANTI-GEN ON THE 3 4 BEN-ZPYRENE IN-DUCED RAT CHON-DROSAR-CO-MA HSN
1-7-3'CL, ESE  EX-TRA SHEEP E ANTI-GEN
WRD8'CL, RHEUMA-TOID FAC-TOR
4.18'CL, KIM11.4
D30'CL, RH D
RA-2-L21'CL, RHEUMA-TOID FAC-TOR
7A4-1/212 SCA'CL, AN-TI-BODY CATAL-Y-SES HY-DROL-Y-SES OF P CHLOROPHENYL ES-TER 3
aCD3'CL, CD3
bkv22'CL, IGG POLY-CLON-AL RHEUMA-TOID FAC-TOR
RF-ET5'CL, RHEUMA-TOID FAC-TOR
MICA 7'CL, GLU-TA-MATE DE-CAR-BOXY-LASE  MA-JOR ISLET CELL AU-TOANTI-GEN
FK-001'CL, PSEU-DOMONAS AERUG-I-NOSA EX-O-TOX-IN A HY-BRIDO-MA
11IC6'CL, AU-TOAN-TI-BODY TO THY-ROGLOB-U-LIN
RA-1-DT7'CL, RHEUMA-TOID FAC-TOR
H37-60'CL, IN-FLUEN-ZA VIRUS HEMAG-GLU-TININ HY-BRIDO-MA
H220-1'CL, A PR 8 34 IN-FLUEN-ZA VIRUS HEMAG-GLU-TININ DI-RECT-ED TO THE CB SITE
2INH13'CL, HU-MAN IN-SULIN
M2 88'CL, MOUSE TYPE II COL-LA-GEN
19A5'CL, RH D
SP1.5'CL, THY-ROID PER-OX-I-DASE AU-TOAN-TI-BODY
clone 5'CL, TIM-O-THY GRASS POLLEN MA-JOR AL-LER-GEN PHI P 5
D76, MOUSE KAP-PA LIGHT CHAIN  P AZOPHENY-LAR-SON-ATE BSA  ARS BSA
VH HER1'CL, LAMIN B AU-TOAN-TI-BODY
126TO8K'CL, THY-ROID PER-OX-I-DASE  TPO
1261P5K'CL, THY-ROID PER-OX-I-DASE  TPO
7-1'CL, IG-G2A
10I'CL, THY-ROID PER-OX-I-DASE AU-TOAN-TI-BODY
EL-14'CL, FAC-TOR VI-II
13D2'CL, RH D
clone 31'CL, TIM-O-THY GRASS POLLEN MA-JOR AL-LER-GEN PHI P 5
N01'CL, RH D
MRA7H'CL, HI-S-T-ONE
THY-32'CL, HU-MAN THY-ROGLOB-U-LIN
WR1.102'CL, THY-ROID PER-OX-I-DASE
CB 334'CL, HU-MAN AND MOUSE TYPE II COL-LA-GEN C1 EPI-TOPE  RESIDUES 316 TO 333
CL-O'CL, ERY-THRO-CYTE
C3'''CL, HU-MAN PARATHY-ROID HOR-M-ONE RE-LAT-ED PRO-TEIN RESIDUES 1 TO 34  KA=2.4X10-EX-P9
VLREN'CL, CD5+
kappa7'CL, HU-MAN THY-ROGLOB-U-LIN
L11-1A1'CL, IN-FLUEN-ZA VIRUS  A PR 8 34  HEMAG-GLU-TININ SEC-ONDARY AN-TI-BOD-IES  SB  HY-BRIDO-MA
N61'CL, HU-MAN N BLOOD GROUP ANTI-GEN
RF-MR41'CL, RHEUMA-TOID FAC-TOR
Hb-6, FOETAL HAEMOGLOBIN  HBF
H36-8'CL, IN-FLUEN-ZA VIRUS  A PR 8 34  HEMAG-GLU-TININ SEC-ONDARY AN-TI-BOD-IES  SB  HY-BRIDO-MA
2-9'CL, IG-G2A
YSE'CL, MYELIN AS-SO-CI-AT-ED GLY-CO-PRO-TEIN AND SUL-FAT-ED GLU-CURON-IC PARA-GLO-BO-SIDE
136/9'CL, AU-TO ID-IO-TYP-IC DE-TER-MI-NANT  ID R  ON MAB 28 12
I09'CL, RH D
36-18'CL, IN-FLUEN-ZA VIRUS  A PR 8 34  HEMAG-GLU-TININ
HG2B10H'CL, GAN-GLIO-SIDE AU-TOAN-TI-BODY  GA1
FLO, CRYO-GLOB-U-LIN WITH IGG AC-TIV-I-TY; B ID-IO-TYPE
CB 105'CL, HU-MAN AND MOUSE TYPE II COL-LA-GEN C1 EPI-TOPE  RESIDUES 316 TO 333
4D12'CL, SM HY-BRIDO-MA
F30-4'CL, ACTIN  MYOSIN  TUBU-LIN  DS-D-NA  SS-D-NA AU-TOAN-TI-BODY  BIND-ING CON-TANTS RANGE BE-TWEEN 10-EX-P6 TO 10-EX-P8
RF-4'CL, IG-G1 RHEUMA-TOID FAC-TOR
19.7, MYELIN OLIGO-DEN-DRO-CYTE GLY-CO-PRO-TEIN  MOG
5D1'CL, HU-MAN PRO-COL-LA-GE-NASE
I04'CL, RH D
RF5-3'CL, IG-G2A
E3-MPO'CL, MYELOPER-OX-I-DASE
H107, HU-MAN H FER-RITIN
P01'CL, RH D
1H6'CL, BO-TULINUM NEU-RO-TOX-IN TYPE A BIND-ING DO-MAIN  BONT A HC
RF6-4'CL, IG-G2A
E12, MESOTHE-LIN
RF-ET6'CL, RHEUMA-TOID FAC-TOR
E03, LYSOZYME HY-BRIDO-MA
9F2H'CL, GAN-GLIO-SIDE AU-TOAN-TI-BODY  GAL-GALNAC BSA
YTH 34.5HL'CL, HU-MAN LYM-PHO-CYTE HY-BRIDO-MA
THY-33'CL, HU-MAN THY-ROGLOB-U-LIN
C1'CL, MOUSE TYPE II COL-LA-GEN
S4 10H'CL, EPI-DER-MAL GROWTH FAC-TOR RE-CEP-TOR
3a4D10'CL, AL-PHA TOX-IN OF CLOSTRID-I-UM PER-FRIN-GENS
WR1.112'CL, THY-ROID PER-OX-I-DASE
126CH'CL, THY-ROID PER-OX-I-DASE  TPO
2INH14'CL, HU-MAN IN-SULIN
BMA 0310EUCIV2'CL, HU-MAN T CELL RE-CEP-TOR HU-MAN-IZED AN-TI-BODY
3910'CL, OE-STR-ONE 3 GLU-CURONIDE
2-4'CL, IG-G2A
L36'CL, AU-TOAN-TI-BODY
RF9-11A'CL, IG-G1
11/32'CL, PRO-GES-TER-ONE HY-BRIDO-MA
145-2C11'CL, MOUSE CD3 COM-PLEX
19'CL, IN-SULIN
126TO9K'CL, THY-ROID PER-OX-I-DASE  TPO
Oak-3'CL, ERY-THRO-CYTE RH D  AL-LOANTI-GEN
G08, LYSOZYME HY-BRIDO-MA
4B4'CL, SM AU-TOAN-TI-BODY HY-BRIDO-MA
kappa8'CL, HU-MAN THY-ROGLOB-U-LIN
B/SB5-41'CL, H4
MP12'CL, HLA CLASS II  DR-B1*11
Vl REN'CL, CAR-DI-OLIPIN BE-TA 2 GLY-CO-PRO-TEIN I AU-TOAN-TI-BODY
RF34'CL, IG-G1 MON-O-CLON-AL AU-TOAN-TI-BODY  RHEUMA-TOID FAC-TOR
L69'CL, HU-MAN CD4
slkv1'CL, IGG POLY-CLON-AL RHEUMA-TOID FAC-TOR
HA-6'CL, ERY-THRO-CYTE
vl6-19'CL, IG-G2A RHEUMA-TOID FAC-TOR
NC1/34HL'CL, SUB-STANCE P
Anti-Leu3a'CL, CD4  IN-HIBIT-ING THE BIND-ING OF HIV GP120 TO CD4
13D10'CL, EAR-LY NU-CLE-O-SOME AU-TOAN-TI-BODY  KD = 2.8X10-EXP 8
JV6, IGG MON-O-CLON-AL AU-TOAN-TI-BODY  RHEUMA-TOID FAC-TOR
A1, DI-HY-DROFLAVONOL 4 RE-DUC-TASE FROM PETU-NIA HY-BRI-DA
CP5 A23-3'CL, BROME-LAIN TREAT-ED MOUSE RED BLOOD CELL HY-BRIDO-MA
ARMVl'CL, MYELIN AS-SO-CI-AT-ED PRO-TEIN
CP5 A21-1'CL, BROME-LAIN TREAT-ED MOUSE RED BLOOD CELL HY-BRIDO-MA
RF-ET7'CL, RHEUMA-TOID FAC-TOR
D07'CL, RH D
2H1, CRYP-TO-CO-CEUS NE-O-FOR-MANS  AN EN-CAP-SU-LAT-ED FUN-GUS THAT CAUS-ES MENIN-GOEN-CEPHALI-TIS
ASWS1'CL, NU-CLE-O-LAR PAR-TI-CLES U3  U8
2INH15'CL, HU-MAN IN-SULIN
MAR'CL, POLYRE-AC-TIVE
Z119VH5'CL, CD20
HP22'CL, PUB-LIC ID-IOTOPE HY-BRIDO-MA OF THE GAT SYS-TEM
SM3, CAR-CI-NO-MA AS-SO-CIATE MUCIN  REC-OG-NIZ-ING THE PEP-TIDE PDTRP
2C8'CL, MOUSE CY-TOCHROME C AROUND RESIDUE 62
PA2'CL, CHRO-MATIN
RF1-9'CL, IG-G2A
SS269, P1.7 PO-RA PRO-TEIN LOOP OF NEIS-SE-RIA MENIN-GI-TIDIS
1D5'CL, BO-TULINUM NEU-RO-TOX-IN TYPE A BIND-ING DO-MAIN  BONT A HC
AIG'CL, FC IGG
R01'CL, RH D
G03, LYSOZYME HY-BRIDO-MA
CUR, CRYO-GLOB-U-LIN WITH IGG AC-TIV-I-TY; B ID-IO-TYPE
NN3'CL, HU-MAN N BLOOD GROUP ANTI-GEN
A73, SM-RNP
F1_1355'CL, FRAC-TION 1
IAG-1, POLYAM-INE  CROSS RE-ACTS WITH SPER-MI-D-INE
1F6'CL, FE-CAL BAC-TE-RIA
RA-2-L5'CL, RHEUMA-TOID FAC-TOR
IC5-3A4'CL, A PR 8 34 IN-FLUEN-ZA VIRUS HEMAG-GLU-TININ DI-RECT-ED TO THE CB SITE
B10H2'CL, THY-ROGLOB-U-LIN AU-TOAN-TI-BODY HY-BRIDO-MA
hsigkvm148'CL, BE-TA AMY-LOID
L2-5D2'CL, A PR 8 34 IN-FLUEN-ZA VIRUS HEMAG-GLU-TININ DI-RECT-ED TO THE CB SITE
I12'CL, RH D
2INH16'CL, HU-MAN IN-SULIN
2INH1'CL, HU-MAN IN-SULIN
SO1'CL, AN-TI9 HLA DQ3
3D8L'CL, MUR-INE SERUM AL-BU-MIN
B'2 (VH3-JH4)'CL, RHEUMA-TOID FAC-TOR
2H7'CL, CD20 CELL SUR-FACE PHOS-PHO-PRO-TEIN HY-BRIDO-MA
D23'CL, POLYRE-AC-TIVE AU-TOAN-TI-BODY HY-BRIDO-MA
scFv-KJ16 mut7'CL, T CELL RE-CEP-TOR  V BE-TA8 RE-GION
M2 76'CL, MOUSE TYPE II COL-LA-GEN
311, TYPE II PNEU-MO-COC-CAL POLY-SAC-CHA-RIDE
131TP14H'CL, THY-ROID PER-OX-I-DASE  TPO
VL A121, CD34
3B12-2'CL, 88 KDA SPLIC-ING FAC-TOR 53 4
RF-MR20'CL, RHEUMA-TOID FAC-TOR
417.F21.5'CL, POLYRE-AC-TIVE
126TP5H'CL, THY-ROID PER-OX-I-DASE  TPO
S3 12D'CL, EPI-DER-MAL GROWTH FAC-TOR RE-CEP-TOR
N901H/KOL, CD56
Y238 scFv'CL, P21 RAS
L16'CL, POLY-DT  CAR-DI-OLIPIN  AND SS-D-NA
TE32'CL, CT-P3
ML1'CL, POLY-DT  AND SS-D-NA
TE33'CL, CT-P3
AL1-3'CL, POLY-CA-TION
AL3-5'CL, POLY-CA-TION
AL1-2'CL, POLY-CA-TION
AL3-4'CL, POLY-CA-TION
AL3-3'CL, POLY-CA-TION
AL3-8'CL, POLY-CA-TION
AL3-2'CL, POLY-CA-TION
Py20, PHOS-PHO-TY-RO-SYL-PRO-TEIN
Py42, PHOS-PHO-TY-RO-SYL-PRO-TEIN
scFv13, BE-TA GALAC-TOSI-DASE
2E9E9'CL, PH-THA-LATE COU-PLED KEY-HOLE LIMPET HEMO-CYANIN
1C4C9'CL, PH-THA-LATE COU-PLED KEY-HOLE LIMPET HEMO-CYANIN
1G8G10'CL, PH-THA-LATE COU-PLED KEY-HOLE LIMPET HEMO-CYANIN
Py2, PHOS-PHO-TY-RO-SYL-PRO-TEIN
1G1B6'CL, PH-THA-LATE COU-PLED KEY-HOLE LIMPET HEMO-CYANIN
6B10D2'CL, PH-THA-LATE COU-PLED KEY-HOLE LIMPET HEMO-CYANIN
Py69, PHOS-PHO-TY-RO-SYL-PRO-TEIN
Py54, PHOS-PHO-TY-RO-SYL-PRO-TEIN
L16'CL, POLY-DT  CAR-DI-OLIPIN  AND SS-D-NA
TE32'CL, CT-P3
ML1'CL, POLY-DT  AND SS-D-NA
TE33'CL, CT-P3
